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ABSTRACT 
Depression has been recognised by the World Health Organisation (WHO) as the 
leading cause of disability, affecting an estimated 300 million people globally. To date 
antidepressants are prescribed as the first step in the treatment strategy. However, 
finding the appropriate antidepressant is often a lengthy process and is usually 
accompanied by side effects. A major and often unexpected side effect is reduced 
sexual function, which has been reported to aggravate depression and could possibly 
lead to poor compliance to medication.  
Sceletium tortuosum is a native South African plant, which has exhibited both 
antidepressant and anxiolytic properties. Although the exact mechanism of action 
remains to be elucidated, there are currently two hypotheses which attempt to 
explain it’s mechanism of action. Firstly, it has been reported to act in the same 
manner as a selective serotonin reuptake inhibitor (SSRI), binding to the serotonin 
transporter and preventing the reuptake of serotonin (5-HT) and thus leading to an 
increase of 5-HT in the synaptic cleft. On the other hand, it has been reported to act 
as a monoamine releasing agent (MRA) which assists with the release of monoamine 
vesicles from the presynaptic neuron, also resulting in an increase of 5-HT in the 
synaptic cleft.  
A strong correlation exists between depression and the hyper-activation of the 
hypothalamus-pituitary-adrenal (HPA) axis. On the other hand, antidepressants and 
MRA’s have been associated with endocrine disruption. Although a human safety 
study has illustrated that S.tortuosum is safe for consumption, it was recently reported 
to decrease sex steroid hormone levels including androstenedione (A4) and 
testosterone (T) in the H295R cell line, but conclusive remarks could not be formulated. 
The objective of this thesis was to establish whether Trimesemine™ (Tri; a mesembrine-
rich S.tortuosum) could adversely affect gonadal steroid synthesis.   
HEK293 cells were transfected with 17βHSD type 5 (17βHSD5) cDNA, resulting in the 
overexpression of the 17βHSD5 enzyme, which is responsible for the conversion of A4 
to T.  Previous studies within our group used Trimesemine™ at doses ranging from 
0.0001 mg/ml to 1 mg/ml. For this study narrower ranges were chosen. The cells were 
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treated with Tri™ at proven effective dose (0.01 mg/ml) and high (0.5 mg/ml) dose, 
the supernatant was removed after 24 hours and the samples were analysed by UPC2-
MS/MS. Routinely euthanized mice were accessed immediately after the culling to 
obtain viable tissue for primary cultures. Testes were removed, decapsulated and a 
mixed culture was plated. After 24 hours the cells were treated with lower and high 
doses of Tri™, following another 24 hours the supernatant was removed and the 
samples were analysed with UPLC-MS/MS. Ovaries were collected, dissociated and 
plated.  The mixed culture was allowed to stabilise for 24 hours. This was followed by 
treatment with Tri™ at lower and high doses for a period of 24 hours, the supernatant 
was removed and the samples were analysed with UPLC-MS/MS. 
 
At the lower dose Tri™ did not appear to have any effect on A4, T and estradiol (E2). 
However, the high dose of Tri™ appeared to decrease A4 (mixed testicular culture) 
and T (HEK293 cells), possibly via inhibition of the 3βHSD or 17βHSD enzymes. In contrast 
no there did not appear to be estrogenic effects. 
 
In conclusion, low dose Tri™ did not appear to exhibit endocrine disruptive properties 
in vitro. These doses are comparable to those recommended for consumer use. The 
adverse effect elicited by the high dose Tri™ could be used as a marker for overdose, 
provided that basal levels of the hormones are known. These positive results indicates 
endocrine safety in vitro, but in vivo data is required for conclusive confirmation. 
 
 
  
Stellenbosch University  https://scholar.sun.ac.za
v 
 
UITTREKSEL 
 
Depressie word deur die Wêreldgesondheidsorganisasie (WHO) erken as die grootste 
oorsaak van ongeskiktheid, wat wêreldwyd sowat 300 miljoen mense raak.  
Tot op datum word antidepressante as die eerste stap in die behandelingstrategie 
voorgeskryf. Om ‘n toepaslike antidepressant te vind is dikwels 'n langdurige proses en 
gaan gewoonlik gepaard met newe-effekte. ‘n Meestal onverwagte newe-effek is 
verminderde seksuele funksie, wat moontlik die depressie kan vererger, of die pasiënt 
‘n rede gee om hul medikasie minder as voorgeskryf te gebruik. 
 
Sceletium tortuosum is 'n inheemse Suid-Afrikaanse plant, wat beide antidepressante 
en teen-angstigheid eienskappe het. Alhoewel die meganisme(s) van aksie van die 
plant nog nie geheel bekend is nie, is daar twee modelle wat dit probeer verduidelik. 
Dit word beweer dat S.tortuosum aan die serotonien reseptor bind om die heropname 
van serotonien te verhoed, en werk dus soos ‘n selektiewe serotonien heropname 
inhibeerder (SSRI) . Die tweede model beweer dat S.tortuosum help met die vrystelling 
van die monoamien neuroseinoordraer uit die presinaptiese neuron,  en dus soos 'n 
monoamien vrystellingsagent (MRA) werk. 
 
Daar is 'n sterk verband tussen depressie en die hiperaktivering van die hipotalamus-
pituïtêre-adrenale (HPA) as. Beide antidepressante en MRA's word geassosieer met 
endokriene ontwrigting. Hoewel ŉ veiligheidstudie bevind het dat S.tortuosum veilig is 
vir menslike gebruik, is dit onlangs gerapporteer  dat daar ‘n moontlikheid is dat dit 
sekere steroïedhormone, soos androstenedioon (A4) en testosteroon (T), kan 
verminder, maar beslissende opmerkings kon nie geformuleer word nie. Die doel van 
hierdie proefskrif was om vas te stel of Trimesemine™ (Tri; mesembrine ryk S.tortuosum) 
moontlik ŉ nadelige effek op steroïedsintese in die testis en/of ovarium het. 
 
HEK293 selle is getransfekteer met 17βHSD tipe 5 (17βHSD5) cDNA, wat lei tot die 
ooruitdrukking van die 17βHSD5 ensiem, wat verantwoordelik is vir die omskakeling van 
A4 na T. Die selle is voorafbehandel met Tri™ teen 'n bewese effektiewe dosis (0.01 
mg / ml) en hoë (0.5 mg / ml) dosis. Na 24 uur was die supernatant verwyder en die 
monsters was ontleed deur gebruik te maak van UPC2-MS/MS. In ŉ opvolgeksperiment 
is primêre gemengde muistestis kulture opgestel. Testisse is verwyder, ontkapsel en 'n 
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gemengde kultuur was uitgeplaat. Na 24 uur is die selle behandel met lae en hoë 
dosisse Tri™. 24 uur later is die supernatant verwyder en die monsters was geanaliseer 
deur behulp van UPLC-MS / MS. Die ovaria is verwyder, fyngemaak en uitgeplaat. Na 
24 uur is die selle behandel met effektiewe en hoë dosisse Tri™. 24 uur later is die 
supernatant verwyder en die monsters was geanaliseer deur behulp van UPC2-MS / 
MS. 
 
By die laer dosis was daar geen nadelige effek op A4, T en estradiool (E2) nie. Die hoë 
dosis Tri™ het egter vlakke van A4 (testikulêre gemengde kultuur) en T (HEK293 selle) 
verminder, moontlik deur inhibisie van 3βHSD of 17βHSD ensieme. Daar was geen 
verandering in die vlakke van E2 gesien nie. 
 
Ten slotte blyk dit dat laer dosis Tri™ nie in vitro endokriene ontwrigtende eienskappe 
vertoon nie. Hierdie dosisse is vergelykbaar met dié wat aanbeveel word vir 
verbruikersgebruik. Die nadelige effek wat deur verhoogde dosisse van Tri™ verkry 
word, kan moontlik as 'n merker vir oordosis gebruik word, indien die basale vlakke 
van die hormone bekend is. Alhoewel die huidige studie dui op endokriene veiligheid 
in vitro, is in vivo data nodig vir voldoende bevestiging hiervan. 
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CHAPTER 1 
INTRODUCTION 
Depression is defined as an altered mental state, associated with feelings of low self-
esteem, a despondent mood and reduced pleasure in daily activities (Bondy, 2002). 
At present the World Health Organisation (WHO) has recognised depression as the 
leading cause of disability, with an estimated 300 million sufferers globally.  
The exact cause of depression remains to be elucidated, but currently there are 
biological, psychological and social models which attempt to explain the onset of the 
disorder. One of these models propose the dysregulation of the hypothalamus-
pituitary-adrenal (HPA) axis (Roy and Campbell, 2013). A hyperactive HPA axis has 
been observed with the onset of depression (Swaab et al., 2005; Chatzittofi et al., 
2016). This hyperactivity results in an increased concentration of cortisol (CORT) within 
the body which has subsequently been associated with an increased susceptibility to 
develop depression. Another renowned model is the monoamine deficiency model 
of depression, this model suggests that depression arises as a result of a decrease or 
imbalance of monoamine neurotransmitters (dopamine (DA) and noradrenaline (NA) 
and serotonin (5-HT)) (Delgado, 2000).  
Antidepressants are currently the first line of therapy to alleviate the depressive 
symptoms. There are several classes of antidepressants and each class operates 
through a different mechanism of action, but ultimately aim to improve the 
individual’s mood. Selective serotonin reuptake inhibitors (SSRI) are usually prescribed 
as the antidepressant of choice, upon initial diagnosis of depression (Jakobsen et al., 
2017). SSRI increase the concentration of 5-HT within the synaptic cleft by preventing 
its re-uptake into the presynaptic neuron. Although antidepressants alleviate the 
depressed symptoms, finding the correct antidepressant is often a lengthy process 
which is accompanied by numerous side effects including nausea, dry skin and 
weight deviations. Sexual dysfunction is a major and often unexpected side effect, 
which could lead to poor self-esteem, relationship tension and feelings of 
inadequacy. This could exacerbate the condition and result in non-compliance of 
medication (Kennedy et al., 1999).  
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Recently alternative and complementary therapies have gained popularity. Several 
natural remedies have been reported to relieve depression, such as St. John’s wort 
and Crocus sativus (Saffron crocus) (Ernst, 2007). Sceletium tortuosum, a plant native 
to South Africa, has obtained interest for is antidepressant and anxiolytic properties 
(Smith, 2011; Nell et al., 2013). Human and animal studies have indicated that it is safe 
for human use, with no reports of serious adverse side effects. Recently, a study by 
Smith and Swart (2016) observed potential undesired effects of Trimesemine™ (a 
mesembrine-rich S.tortuosum) on the steroidogenic pathway, as demonstrated in an 
adrenal cell culture model (H295R). This observation could indicate possible 
endocrine disruptive effect, which remains to be clarified.  
As the endocrine system is critical for the regulation and overall function of the 
organism, understanding the adverse effects caused by compounds is essential. In 
human and animal studies it has been reported that antidepressants decreased 
testosterone (T) concentrations (Gregorian et al., 2002). Specifically, in aqueous 
environments antidepressants such as flovoxetine, sertraline and citalopram had 
endocrine disruptive effects (Mennigen et al., 2008; Mennigen et al., 2010; Soga et al., 
2012). MRA’s have also reportedly contributed to disruptions of the endocrine system. 
Owing to the mechanism of action (SSRI or MRA) of S.tortuosum as well as the 
indicative endocrine changes reported by Smith and Swart (2016), determining the 
effect in the context of gonadal steroid synthesis is essential.  
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CHAPTER 2 
LITERATURE REVIEW 
This literature review will offer a basic physiological overview in an attempt to describe 
the HPA and hypothalamus-pituitary-gonadal (HPG) axis as well as their interaction. In 
order to place this research in context, a more basic physiology will be followed by a 
discussion of what is known about the causes of depression, as well as the different 
treatment options. Furthermore, the negative side-effects associated with 
conventional treatments will also be highlighted. This will be followed by an overview 
of literature pertaining to a natural plant extract which shows promise in the context 
of depression.  
 
2.1 Steroidogenesis 
The process of synthesising steroids is known as steroidogenesis. This process occurs at 
several sites within the body including the adrenals, gonads, the brain and placenta 
(Tamaoki, 1972). Steroids synthesised within the body, are termed endogenous 
steroids and these are critical for the development and maintenance of life. 
Endogenous steroids are grouped into five classes namely: estrogens, progestins, 
androgens, glucocorticoids and mineralocorticoids (Giguère et al., 1988; Miller, 2013). 
For the purpose of this review the focus centres around the production of sex steroids 
and the potential effects produced by endocrine disruptors on these steroids.  
Steroids are not stored but synthesised as required by the body. Cholesterol is essential 
to the process of steroidogenesis, as it is the precursor for all steroids. Although some 
organs, such as the adrenals are capable of de novo synthesis, the preferred source 
of cholesterol is low density lipoproteins (Miller, 1998; Liu et al., 2005). One of the rate 
limiting steps of steroidogenesis is the quantity of cholesterol. The process of steroid 
synthesis is governed by the steroidogenic acute regulatory protein (StAR), which is 
responsible for the movement of cholesterol from the outer mitochondrial membrane 
(OMM) to the inner mitochondrial membrane (IMM). Cholesterol will bind to StAR 
situated on the OMM, this interaction will promote a conformational change in StAR 
resulting in the release of cholesterol to the IMM (Miller, 2007; Rone et al., 2009).  
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2.1.1 Adrenal Steroidogenesis 
Adrenocorticotrophin hormone (ACTH) regulates adrenal steroidogenesis and this 
regulation occurs at three different time courses. Firstly, the long term effect (months 
or weeks) of ACTH can be observed by the process of hyperplasia and hypertrophy, 
thus governing the size of the adrenals.  Secondly, over the course of days, ACTH 
promotes the expression of steroid enzymes, influencing the concentration of 
steroidogenic machinery. Thirdly, ACTH almost instantaneously stimulates the onset of 
steroid biosynthesis in response to the demands of the body (Grahame-Smith et al., 
1967; Miller, 2017). There are two enzymatic groups which are crucial for the 
production of steroid hormones, namely hydroxysteroid dehydrogenases (HSD) and 
cytochrome P450 (P450s) enzymes.  
 
The adrenals have three distinct layers: the zona glomerulosa, zona fasiculata and 
zona reticularis and each zone is responsible for the production of different steroids: 
mineralocorticoids, glucocorticoids and gonadocorticoids respectively. As a result of 
this the zones require different enzymatic machinery. The zona glomerulosa contains 
aldosterone synthase (P450c11AS), which is required for the conversion 
11-deoxycorticosterone (DOC) to aldosterone (ALDO). Cytochrome P450 11β-
hydroxylase (P450c11β) is present in the zona fasiculata and it promotes 
glucocorticoid synthesis. Unique to the zona reticularis is the enzyme aromatase 
(P450aro), which aids the transition of androgens to estrogens (gonadocorticoids). The 
initial step in steroid synthesis requires P450 side chain cleavage (P450scc/CYP11A1), 
which is responsible for the conversion of cholesterol to pregnenolone (PREG). 
Therefore P450scc is present in all steroidogenic tissue (Hanukoglu, 1992; Jefcoate et 
al., 1992). Another P450 enzyme which is critical for the steroid synthesis is Cytochrome 
P450 17α-hydroxylase/17,-20-lyase (P450c17). This enzyme has dual activity and is the 
branch point in the synthesis of glucocorticoids or gonadocorticoids (Chung et al., 
1987; Brock and Waterman, 1999; Schloms, 2015) (as depicted in Fig.2.1). 
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Figure. 2.1. Steroidogenic pathway present in the adrenal cortex (Smith and Swart, 2016) 
 
 
 
2.1.2 Gonadal Steroid Synthesis 
The Leydig cells are responsible for testosterone (T) production within the testes (Zirkin 
and Chen, 2000; Saez et al., 1983). Unlike the adrenal cells, Leydig cells do not express 
sulfatases, preventing the conversion of dehydroepiandrostenedione (DHEA) to 
dehydroepiandrostenedione-sulfate (DHEA-S). The absence of these enzymes 
increases the concentration of substrate for T production. The final steps in androgen 
synthesis is the conversion of androstenedione (A4) to T and in some cases T is 
converted to its more active form dihydrotestosterone  (DHT), via 17βHSD3 or 17βHSD5  
and 5α-reductase enzymes respectively (Luu-The, 2001; Miller and Auchus, 
2011)(Fig.2.2). 
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Fig.2.2. Steroidogenesis in the Leydig Cells 
           
Steroid synthesis in the Leydig cells, along with the enzymes essential to the pathway. 
Steroidogenic acute regulatory protein (StAR); Cholesterol side chain cleavage 
(P450scc); 3βHSD; 17βHSD; 5-ARD; P450aro. The dotted lines represent the steroid 
pathway from PREG to DHEA (Adapted from Odermatt et al., 2016) 
 
Unlike the testes, steroidogenesis within the ovary occurs in a multistep manner, 
involving the theca and granulosa cells. Cholesterol will enter the theca cells, it  will 
be converted to PREG and subsequently to A4 and T. These androgens then move 
into the granulosa cells, where they will be converted into estrogens, esterone (E1) 
and estrodiol (E2), by means of aromatase enzyme(Payne and Hales, 2004)(Fig.2.3). 
E2 will be transported out of the granulosa cell and bind to an estrogen receptor of 
choice, resulting in a desired response. 
Fig.2.3 The steroid synthesis in the ovaries.  
            
Cholesterol moves into the mitochondria and is cleaved by P450scc. In the Theca cells 
(pink block) cholesterol is converted to A4 or T, this then moves (green arrows) to the 
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granulosa cells (blue block). T could also leave the Theca cells at this point (purple arrow). 
In the granulosa cells A4 and T are converted to estrone (E1) and estradiol (E2) via P450aro 
, and this hormone will move out of the granulosa cells (Adapted from Bloom et al., 2016). 
It is important to note that steroid production is under endocrine control and therefor 
the two main axes which are implicated will be briefly discussed. 
 
2.2 The hypothalamus-pituitary-adrenal (HPA) axis 
Stress is defined as any stimulus that disrupts homeostasis of the organism, this 
disruption is countered by an appropriate response which was initiated by the HPA 
axis. In the late eighties and early to mid-nineties researchers aimed to clarify the 
definition of a stressor, the response it initiates and how the body adapts to the 
disruption. The well-known “fight or flight” term was coined by W. Cannon ( Cannon, 
1929; Johnson et al., 1992) which suggests that the presence of a threat will result in 
an action of moving toward or away from the threat (Cannon, 1932) . H. Seyle (1950) 
elaborated on this model and named it the “General Adaption Syndrome”. This 
model comprises of three phases:  #1. The Alarm Phase; here the body recognises the 
stressor, activating the sympathetic nervous system (SNS) and resulting in a surge of 
CORT and epinephrine. #2. The Phase of Resistance; during this phase the body 
adapts to the stressor, allowing the organism to function optimally in the presence of 
the stressor. CORT and epinephrine will remain upregulated. #3. The Phase of 
Exhaustion; occurs under chronic stress conditions. During this phase the metabolic 
load can no longer be maintained as resources have been depleted, this phase is 
often accompanied by other disorders such as diabetes or cardiovascular disorders 
(Seyle, 1950; Seyle, 1951; Handa and Weiser, 2014). 
Under normal physiological conditions a stimulus (eg. threat, pain, emotion) activates 
the HPA axis. This stimulus activates the paraventricular nuclei in the hypothalamus to 
secrete corticotrophin releasing hormone (CRH). Which in turn stimulates the anterior 
pituitary to secrete ACTH, resulting in the release of glucocorticoids (cortisol (humans) 
or corticosterone (rodents))  from the adrenal cortex (Anisman et al.,1999). 
Simultaneously, the locus ceruleus–norepinephrine autonomic (LC-NE) system is 
activated. This promotes the secretion of norepinephrine (NE) into the blood which in 
turn will increase the heart rate, blood pressure and mental alertness (Johnson et al., 
1992; Tsigos and Chrousos, 2002; Handa and Weiser, 2014). In the absence of a stressor, 
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or after neutralisation of the stress stimulus, the body will re-vert back to baseline 
(Sherwood, 2008).  This down-regulation of the HPA axis occurs through negative 
feedback, as the glucocorticoids act as inhibitors of the system (Tsigos and Chrousos, 
2002; Hosseinichimeh et al., 2015) (Fig.2.4). 
Fig.2.4. HPA axis.  
            
Solid lines present stimulation while the dashed line represent inhibition. 
 
In altered physiologic conditions such as chronic stress, HPA dysregulation appears to 
ensue ( Anisman et al., 1999; Tsigos and Chrousos, 2002; Raone et al., 2007), This 
dysregulation is often in the form of increased activity, resulting in excessive 
glucocorticoids, which in turn has widespread adverse effects (Johnson et al., 1992).   
Interestingly, it has been observed that there are gender differences during the stress 
response and during the reproductive years these differences are more noticeable 
(Nolen-Hoeksema, 1987; Meller et al., 200). Wang et al., (2007) reported increased 
activation of the HPA-axis in men during performance tasks, while women showed a 
stronger activation during uncomfortable interpersonal encounters.  
 
2.3 The hypothalamus-pituitary-gonadal (HPG) axis 
Similar to the HPA, the HPG axis starts in the hypothalamus, with the pulsatile release 
of gonadotrophin releasing hormone (GnRH). GnRH stimulates gonadotropic cells in 
the anterior pituitary to release gondatotropins: follicle stimulating hormone (FSH) and 
luteinising hormone (LH). These gonadotrophins are glycoprotein heterodimers, 
consisting of an α- and β-subunit. LH secretion is pulsatile and has been associated 
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with the pulsatile rhythm of GnRH. However, FSH secretion does not appear to have 
the same association with GnRH. These gonadotrophins will stimulate the release of 
sex steroids (estrogen, progesterone and T) from the gonads (ovary and testes) (Jin 
and Yang, 2014; Cross, 2017)(Fig.2.5).  
Fig.2.5. HPG axis.  
             
Solid lines represent stimulation while the negative lines represent inhibition 
These gonadotrophins have a particularly important role during the menstrual cycle. 
Throughout the cycle FSH and LH will fluctuate (Fig.2.6). The follicular phase is 
characterised by higher FSH concentrations, which will in turn stimulate the production 
of estrogen and promote follicular growth. Low levels of E2 from the developing follicle 
inhibits the release of LH but when E2 surpasses its inhibitory threshold, the inhibitory 
effect is lost and a surge in LH will ensue. This surge will initiate ovulation and an oocyte 
will be released. Lastly the luteal phase is characterised by high levels of progesterone 
(PROG), which has an inhibitory effect on LH and FSH.  While the corpus luteum 
atrophies PROG decreases and LH and FSH will increase steadily (Hawkins and Matzuk, 
2008; Sherwood, 2008; Cross, 2017).  
Fig.2.6. Hormonal fluctuations during the menstrual cycle. 
            
Ovulation is indicated by the black vertical line. Hormones are indicated as follows: 
progesterone (green), estrogen (blue), LH (brown), FSH (pink). 
LH 
Estrogen 
Progesterone 
FSH 
 Hypothalamus 
Anterior 
Pituitary 
Gonads 
Gonadocorticoids 
Gonadotrophins 
GnRH 
Stellenbosch University  https://scholar.sun.ac.za
10 
 
In males FSH and LH will also have reproductive roles. LH will bind to the receptors on 
the Leydig cells which will then promote the secretion of the T. FSH will bind to the 
Sertoli cells to provide an optimal conditions for spermatogenesis. Together, FSH and 
T allow for the maturation of sperm cells (Sherwood, 2008; Jin and Yang, 2014; Coss, 
2017). 
The HPG is also regulated through negative feedback, as the gonadal steroids will 
exert an inhibitory effect on GnRH, FSH and LH (Fig.2.5). This tight regulation between 
these hormones are critical for optimal reproductive function and thus any disruption 
in homeostasis of this system can lead to pathologies. For example, chronically high 
LH in women has been associated with the onset of polycystic ovary syndrome (PCOS) 
and high FSH has been linked to primary ovarian failure. While low T in men has been 
associated with infertility and poor semen quality (Sanderson, 2006; Cross, 2017; Sifakis 
et al., 2017). There are various factors which could lead to HPG dysregulation, 
including stress, endocrine disruptors, physical abnormalities, surgery and certain 
medications (Hutchinson, 2002; Sanderson, 2006; Bloom et al., 2016).  
 
2.4 Functional connectivity of the HPA and HPG axes 
Considering that both the HPA and HPG axes start within the hypothalamus and that 
both involve the pituitary gland, an interaction between the systems have been 
suggested (Roy and Campbell, 2013). During stress, the body will terminate activity of 
all non-essential process, such as reproduction (Rivier and Rivest, 1991; Angold et al., 
1999; Young and Korzun, 2002). Conversely, the HPG axis has been reported to inhibit 
the function of the HPA. It has been suggested that the end products of each axis is 
responsible for this inhibitory cross-talk (Viau, 2002)(Fig.2.7). 
During adolescence there is a shift in the production of sex steroids from the adrenals 
to the gonads, this requires the activation of the HPG axis. During this period of life 
there is also increased pressure and conflict with oneself, parents and others, resulting 
in HPA activation. Therefore, it has been proposed that the HPA and HPG axis can 
function in unison, particularly during the period of adolescence (Johnson et al., 2013; 
Green and McCormick, 2016). In a review by Rivier and Rivest (1991), a prominent 
relationship between stress and the activity of the HPG was highlighted. From their 
literature search they concluded that the effect of stress on the reproductive function 
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is present but the severity of this interaction is governed by factors such as the duration 
and intensity of stress.  Viau et al., (1999), reported that there is cross-talk between the 
HPA and HPG, via the end products CORT and T on hormones CRH and AVP.  
Fig.2.7. Interaction between the HPA and HPG axes. 
 
Interaction between the HPA and HPG axis (primary sites of cortisol and sex steroid production 
are indicated). The dashed line represents inhibition, while the solid lines are stimulation. 
In the next section, we turn the attention to depression, with a discussion on the 
causes, as well as endocrine maladaptation which is commonly reported. 
 
2.5 Depression 
Globally 300 million individuals are reported to suffer from depression (WHO, 2017). 
Depression is classified as a mental disorder and is currently recognised by the World 
Health Organisation (WHO) as the leading cause of disability. When people appear 
to be saddened by certain life events they are carelessly called depressed. However 
it is important to recognise that depression is a serious and debilitating disorder that 
should be taken more seriously. Numerous individuals will experience symptoms of 
depression throughout their lives, however not all will be diagnosed with depression. 
In order to be diagnosed as depressed, individuals need to present five of the 
following nine symptoms over a two week period: despondent mood, considerable 
changes in weight or appetite, marked changes in sleeping pattern (insomnia or 
hypersomnia), diminished or excessive psychomotor activity, chronic exhaustion, poor 
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concentration, suicidal thoughts or tendencies and feelings of worthlessness (Bondy, 
2002; Nestler et al., 2002).  
Depression is a complex disorder which varies between individuals in the onset, 
severity, symptoms and effective treatment. Although research has aimed to clarify 
potential causes for the disorder, to date a single causative factor has not been 
identified (Nestler et al., 2002; WHO, 2017). Although the exact cause for depression 
remains unclear, a host of models have been formulated in an attempt to elucidate 
the onset of the disorder. These models have biological, psychological or social origins 
and each will briefly discussed in the next section. 
2.5.1 Potential biological aetiologies 
2.5.1.1 HPA axis dysregulation 
Depression has been strongly associated with the hyperactivity of the HPA axis. To 
establish HPA dysregulation CRH, ACTH and CORT concentrations are measured. The 
dexamethasone suppression test (DST) test is often used to determine the HPA 
response to cortisol. During this test Dexamethesone is administered at a low dose of 
1 mg, following the the cortisol is evaluated to determine the response, if there is a 
decrease in CRH, ACTH and cortisol, the HPA axis is functioning correctly. However, if 
this is not the case a dose of 8 mg will be administered, to determine the reason for 
the excessive cortisol concentrations (Rybakowski et al., 1999). Studies have reported 
mixed results with the DST. Some studies have reported an increase in CORT 
concentrations at awakening and in the evening (Vreeburg et al., 2009). In support of 
this, studies have observed enlarged pituitary and adrenal glands (reviewed by Roy 
and Campbell, 2013). While others recognise there is an increased cortisol 
concentration at basal levels, but state that the stress response is dampened 
(Varghese and Brown, 2001; Burke et al., 2005). It is important to note that the studies 
available in literature employ different methods and acquire samples at different 
times of the day using different stressors, offering a possible explanation for the 
different findings (Burke et al., 2005; Powers et al, 2016). 
2.5.1.2 Monoamine Deficiency Model of Depression  
Neurotransmitters are chemical messengers used by neurons for communication, to 
produce a desired effect. Those neurotransmitters which are relevant to depression 
are collectively known as monoamine neurotransmitters and include dopamine (DA), 
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noradrenaline (NA) and serotonin (5-HT). They are released from the presynaptic 
neuron into the synaptic cleft and then bind to receptors on the post-synaptic neuron 
(Sherwood, 2008). In the absence of a signal stimulating their release, they will return 
to the presynaptic neuron through endocytosis or undergo degradation by the 
monoamine oxidase (MAO) enzyme (Sherwood, 2008). Depressed individuals are 
reported to have lower concentrations of 5-HT relative to healthy controls.  Therefore, 
current and developing therapies have aimed at increasing the amount of these 
neurotransmitters in an attempt to alleviate the despondent mood. To establish the 
importance of 5-HT in the context of depression tryptophan (5-HT precursor) depletion 
studies have been performed and reported an increase in depression-like symptoms. 
Additionally, the use of antidepressants elevate the concentration of these 
monoamines (Janowsky et al., 1972; van Praag et al., 1990; Delgado, 2000; Hirschfeld, 
2000; Roy and Campbell, 2013). 
Although these hold a relevancy to this thesis there are still more models which aim to 
explain the onset of this complex disorder. The macrophage model of depression 
proposes that the disorder is similar to an illness, and that inflammation present within 
the body results in the depressive symptoms (Maes et al., 2009; Roy and Campbell, 
2013). In post-mortem studies of depressed individuals structural abnormalities are 
common. It is suggested that these changes are brought about by the loss of 
neurogenesis and neuroplasticity. This contributes to atrophy within the brain leading 
to hippocampal volume loss and increasing the risk for the onset of depression 
(Bremner et al., 2000). Often antidepressants increase neuronal growth factors such 
as brain derived neurotrophic factor (BDNF) and neuropeptide Y (NPY) which assist 
with these processes (Smith et al., 1995; Drevets et al., 2008; Roy and Campbell, 2013). 
The vulnerability for the onset of depression, is increased with genetic polymorphisms, 
specifically in the gene coding for the serotonin transporter promoter region (5-
HTTLPR) (Nestler et al., 2002). 
2.5.1.3 Possible Psychosocial Factors 
The emotional and mental aspects of depression are incorporated in the 
psychological models which include psychodynamic, behavioural and cognitive 
hypotheses.  The psychodynamic hypothesis suggests the conscious and 
subconscious mind are constantly at conflict with each other and that an imbalance 
between these will result in depression. This model is used to explain the risk for 
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developing depression in those who have experienced early life trauma. It has been 
proposed that the manifestation of altered emotions and behaviour later in life occurs 
in response to poor emotional processing in children under traumatic (Nemade, 2014). 
The behavioural hypothesis states depression is learnt and that it can be unlearned. 
Furthermore, it also postulates the loss of the reward system, resulting in a subsequent 
loss of motivation and pleasure, which in turn increases the vulnerability for depression 
(Harmer et al., 2004; Nemade, 2014). The cognitive hypothesis reasons that depressed 
individuals have a negative bias in their thought processing, observing the negatives 
and negating the positives – thus increasing the likelihood of developing a 
despondent mood which could lead to depression (Beck and Clarke, 2010; Nemade 
et al., 2014). 
2.5.2 Social factors  
Social and cultural influences dictate which emotions are deemed acceptable for 
certain genders. Traditionally, women are tasked with child rearing and often 
manage a career, this could lead to her neglecting her own needs which will increase 
the vulnerability to develop depression (Abbey, 1991).Contrastingly, men have been 
raised to believe that a portrayal of their emotions shows reduced masculinity. The 
suppression of their emotions could result in chronic internal emotional turmoil which 
could increase their risk for the development of depression. This contributes to the poor 
diagnosis of depression in men, as these repressed emotions are regularly expressed 
as chronic pain, recurring disease or physical burdens e.g. headaches (Sewpaul, 1999; 
Nemade et al., 2014). 
2.5.3 Gonadal hormone maladaption  
As highlighted earlier, the HPA and HPG can interact with each other. It is important 
to remember that the end products each axis can result in the inhibition of its own 
axis, as well as the other axis (Fig.2.6). In the context of depression there is a strong 
association between the HPA and HPG axes. It has been observed that a hyperactive 
HPA axis, results in excessive CORT production, down-regulating the function of the 
HPG axis, consequently resulting in lowered T levels (Amiaz and Seidman, 2008).  
Additionally, there seems to be a clear gender difference in the prevalence of 
depression, with women appearing to be more susceptible. However, women have 
been reported to seek professional help more readily than men, which could establish 
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the skewed gender difference (Möller-Leimkühler, 2002). Gonadal steroids exert an 
inhibitory effect on GnRH, and can also inhibit CRH. Early onset of depression is 
characterised by excessive levels of CORT and hyperactivity of the HPA axis, thus 
sharing traits associated with conditions such as amenorrhea and anorexia induced 
by chronic, severe exercise. In both these conditions individuals experience weight 
loss, increased CRH and disturbances of the menstrual cycle. The high CRH will also 
leads to inhibition of GnRH, which in turn will lead to decreased FSH, LH, estrogen and 
progesterone (PROG) (reviewed by Young and Korszun, 2002). Depression is often 
associated with excessive weight loss, which can contribute to reduced levels of E2 
and PROG, along with a down regulation of the genes for the estrogen receptor α, 
progesterone receptor, FSH and LH, which in turn will have adverse reproductive 
implications (Zhou et aI., 2014).  
Men with depression have been reported to have lowered T levels (Schweiger, 1999). 
This decrease in T with depression was also observed by McIntyre et al., (2006). 
Although it remains unclear whether the decreased T could result in depressed or 
whether the depressive state reduces the T levels (Mikkelson et al., 2012). 
In a study by Wang et al., (2007) it was noted that using mental arithmetic tasks as the 
stress stimulus, men and women responded differently. Interestingly, men experienced 
an increase in salivary CORT while women did not. Giltay et al., (2012) observed a 
positive correlation between T and psychological disorders in women but not men. 
Opposing this Welker et al., (2014) found an association between CORT and T in men 
but failed to yield the same results for women. While Powers et al., (2016) noted that 
depression in women was associated with lower CORT, while anxiety was associated 
with increased CORT. Furthermore, they observed increased CORT levels in depressed 
men.  
In summary, from the literature, it is evident that males and females differ in their 
physiological response to stress. Perhaps in part due to the fact that the genders differ 
in terms of the relative stress vs. anxiety experienced in response to any particular 
stressor. In this context it is imperative to include both genders in research. Additionally, 
in the context of depression, maladaptation has been described in several different 
systems. This includes reduced reproductive function as a result of altered genes, 
reduced secretion of hormones and inhibition of the HPG axis (Viau, 2002). Despite 
this known effect of depression on the HPG axis, it seems that conventional western 
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medicine prescribed for depression largely fails to address the effect of depression on 
the reproductive system. When developing new treatment modalities it is important 
to consider not only, their capacity to alleviate the undesired deviations from 
homeostasis but also to ensure that the treatment does not aggravate any of these 
maladaptations. I provide a brief overview of commonly used antidepressants, in 
terms of their effect on the endocrine system. 
 
2.6 Antidepressants 
Presently, the first line of therapy for the treatment of depression is antidepressants. 
Considering the complexity of depression, finding the appropriate type of 
antidepressant and ideal dosage is often a lengthy process (O'Leary et al., 2013). 
Although antidepressants produce immediate changes at a molecular level, it takes 
weeks to months of use for observable improvement in mood and well-being (Stahl, 
1998).  
There are five classes of commonly used antidepressant:  
 Monoamine Oxidase Inhibitors (MAOI): inhibit the action of monoamine 
oxidase, the enzyme which is responsible for the breakdown of monoamine 
neurotransmitters.  
 Noradrenergic and specific serotonergic antidepressant (NaSSA):  responsible 
for blocking negative feedback effect on 5-HT and NA. 
 Serotonin and Noradrenaline Reuptake Inhibitors (SNRI): block the reuptake of 
both 5-HT as well as NA.  
 Serotonin Reuptake Inhibitors (SSRI): inhibit the serotonin transporter (SERT), thus 
preventing the reuptake of 5-HT in the presynaptic cell.  
 Tricyclic Antidepressants (TCA): prevent the reuptake of NA into the 
presynaptic cell (Werneke et al., 2006).  
First generation antidepressants such as TCA or MOAI, act on numerous sites, thus 
increasing the probability of side effects (Anderson, 1998). Newer antidepressant such 
as SSRI and SNRI focus on single monoaminergic neurotransmitters, reducing the 
incidence and severity of side effects, ultimately increasing the likelihood of drug 
compliance (Gregorian et al., 2002).  One of the most debilitating side effects which 
have been experienced after use of antidepressant medication, is diminished sexual 
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functioning (Safarinejad, 2008). The psychological stress associated with this 
perceived inadequacy can itself exacerbate the depressive state (Abbey, 1991). 
Thus, it is imperative to understand the underlying cause of this problem – which results 
from endocrine disruption. 
 
2.7 Endocrine disruptors 
Recently, investigations to determine the effects of endocrine disruptors has risen. 
Endocrine disruptors are defined as chemicals which lead to a dysregulation of 
hormone production, hinder hormonal actions or alter developmental processes 
which are under hormonal control (Sifakis et al., 2017). Endocrine disruptors include 
the likes of pharmaceuticals, plastics and xeno-estrogens (herbicides, pesticides and 
fungicides) (Whitehead and Rice, 2006; Kabir et al., 2015). For the purpose of this thesis, 
the focus will be on pharmaceutical endocrine disruptors. 
Using the goldfish model, a commonly accepted model for this purpose, several 
antidepressants have demonstrated endocrine disruptive effects (Mennigen et al., 
2010). It was observed that, 54 µg/L fluoxetine (an SSRI and the active ingredient in 
Prozac), added directly to the water in the fish tank, inhibited both basal and 
pheromone-induced T production in sexually mature male goldfish (Mennigen et al., 
2010). Using female goldfish, the same group also reported an increase of central E2 
levels, after fluoxetine was administered with an intraperitioneal injection (Mennigen 
et al., 2008). However, this study also noted that the plasma levels of E2 were reduced, 
leading to the conclusion that increased central E2 production may down-regulate 
the HPG axis.   
However this is, contradictory to results which was reported for mianserin a TCA 
antidepressant. Mianserin had estrogenic effects both centrally and in the gonads of 
both male and female zebrafish (Van der Ven et al., 2006). Incidentally, in this study, 
the estrogenic effects were paralleled by reduced T levels, which again highlights an 
undesired effect on androgen production. Very recently, Islin et al., (2017) also 
reported similar estrogen increasing and T decreasing effects for some SNRI 
antidepressants (duloxetine, venlafaxine and tramadol) in zebrafish. Their results 
indicated that doses above 20 µM produced inhibitory effects for the CYP17 and 
CYP21 enzymes – resulting in reduced T, A4 and 11βhydroxy-androstenedione 
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(11βOHA4) – but appeared to increase the activity of the CYP19 enzyme (aromatase) 
thus increasing estrogen.  
Similar endocrine disruptive effects have been illustrated using rodent models. For 
example, chronic administration (21 and 28 days) of Citalopram – another SSRI – has 
been shown to reduce the RF-amide related peptide (RFRP) neuronal numbers in the 
dorsomedial hypothalamus, as well as fiber projections to the preoptic-GnRH neurons 
(Soga et al., 2010). Of specific concern for this particular SSRI, is the potential for 
transgenerational propagation of endocrine disruption. This potential adverse effect 
has been illustrated in male mice which were exposed to Citalopram early in life 
(postnatal days 8-21, simulating mother-to-breastfeeding offspring transfer (Soga et 
al., 2012). Apart from increased anxiety-behaviour, mice also exhibited decreased 
androgen receptor levels, which could explain the altered sexual behaviour reported 
in these animals.   Most recently, these results were also confirmed for the six most 
widely used SSRI drugs (fluoxetine, paroxetine, citalopram, escitalopram, sertraline 
and fluvoxamine) in a human adrenocortical cell line (H295R) (Hansen et al., 2017), 
again implicating CYP17 inhibition. 
In terms of the newly developed NaSSA drugs, I could find no information in the 
context of endocrine disruption. Given the impact on reproductive dysfunction, this 
remains to be investigated. 
Although not technically classified as antidepressant medicine, it is known that many 
individuals suffering from depression may resort to consumption of illegal products, 
such as the MRAs, amphetamine and MDMA (Ecstacy)(Boyd, 1993; Huizink et al., 
2006). Given the effect of MRAs to increase 5-HT, DA or NA signalling, it is perhaps not 
unexpected that in terms of endocrine disruption, similar undesirable effects have 
been recorded for these drugs (Barenys et al., 2009; Barenys et al., 2010). 
Amphetamine treatment (which exerts it action through the dopaminergic system) 
has been shown to reduce T production in rat testicular interstitial cells by inhibition of 
the 3βHSD, CYP17 and 17βHSD enzymes (Tsai et al., 1997). Similarly, treatment with 
MDMA (which functions via the serotonergic system) caused testicular degeneration 
in rats (Barenys et al., 2009), suggesting a direct inhibitory effect on T as outcome. In 
addition, a central inhibitory effect on the HPG axis was also reported for MDMA, 
which again resulted in decreased T levels in male rats (Dickerson et al., 2008). 
Although, research in females was not available for MDMA or amphetamine 
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specifically in this context, other so-called “party pills” - benzylpiperazine (BZP) and 
trifluoromethylphenylpiperazine (TFMPP), which function similarly to MDMA – have 
been shown to have estrogenic effects in female rodents (Min et al., 2012). 
Futhermore, given the consumer bias toward using natural products, phytoestrogens 
is another group of compounds that should perhaps be mentioned here. 
Phytoestrogens are compounds present in plants, that have a similar structure to that 
of estrogen (Mense et al., 2008). There is still considerable controversy regarding the 
safety of these compounds (Whitehead and Rice, 2006;  Mense et al., 2008; Velentzis 
et al., 2008), some arguing it has anti-cancer effects (Ingram et al., 1997) while others 
postulate adverse effects, including risk of estrogen-related disorders owing to the 
increase of circulating estrogen levels (Sakamoto et al., 2010; Nielsen, et al., 2015).  
The rise in depression in modern societies is reflected with increased antidepressant 
consumption and although it prompted the development of new antidepressants, no 
evidence is available to suggest that these newer drugs will have less endocrine 
disruptive effects. This, as well as the high cost of conventional medication, has 
encouraged a shift toward the use of alternative therapies, although these treatments 
also have the potential for endocrine disruption. For this reason, it has become 
essential to determine the effect of any treatment modality – whether 
pharmaceutical or nutraceutical – on the endocrine system. 
One of these alternative regimes include the treatment with exogenous gonadal 
steroids. Schmidt et al., (1999) suggested that depressed peri-menopausal women 
reported improved mood when receiving oral 17β-Estradiol supplementation. 
Similarly, Galea et al., (2002) reported that treatment with E2 improves the behaviour 
of an animal model for post-partum depression. From this data, it seems that hormone 
therapy may be a consideration as treatment for depression.However, hormone 
therapy is known to have other side-effects, such as increased risk for some types of 
cancer and stroke (Million Women Study Collaborators, 2003; Vigen, 2013). Another 
option for treatment entails a more holistic approach, such as that set out by Sarris 
(2011). Sarris proposes that a treatment strategy based on the non-pharmacological 
antidepressant-lifestyle-psychological-social model, could yield improved mood, as it 
aims to improve the general well-being. However, this approach may have poor 
compliance, as it is not always possible to remove stress from the modern lifestyle. 
Therefore, a third, more feasible option, is to turn to natural remedies with potential 
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antidepressant activities, but hopefully without the undesired endocrine disruptive 
effects reported for many pharmaceutical antidepressants. 
Over the past few years there has been a growing preference for complementary 
and alternative medicine (CAM). Additionally, traditional healers are often the 
primary healthcare practitioners for those living in rural areas, specifically in 
developing countries as the rural communities are not in close proximity to clinics or 
hospitals (Ernst, 2000; Coulter and Willis, 2004; Sato, 2011; Goroll, 2014; Burns and 
Tomita, 2015). The three primary reasons for the preference of complementary 
medicine include: the dissatisfaction with conventional treatment strategies, an 
increased need to be in control of their health care choices and lastly CAM often 
aligns with patient’s perceptions, cultural and religious belief systems. Under closer 
investigation, it was noted that the latter offered convincing support for the reason 
why people make use of CAM (Astin, 1998; Sorsdahl et al., 2009).   
Although, CAM offers numerous beneficial effects, it is important that these natural 
remedies undergo the same efficacy, efficiency and safety evaluations as 
pharmaceutical medications (Firenzuoli and Gori, 2007; Sato, 2011; Goroll, 2014).  
 
2.8 Sceletium tortuosum 
In the context of anxiety and depression, Sceletium sp. has gained much interest. 
Various species of Sceletium alkaloids have been extracted and studied (Shamma 
and Rodriguez, 1968; Arndt and Kruger, 1970). Sceletium tortuosum is part of the 
Mesembryanthemaceae family and is present natively in the Western and Northern 
Cape of South Africa. The plant received its name from its phenotypic characteristics: 
Sceletus (skeleton-like) owing to its veiny leaves and tortuosum, which means twisted 
(Gericke and Viljoen, 2008).  
Anecdotally, the South African native Khoi and Hottentot populations used this plant 
for medicinal purposes to alleviate a variety of common ailments, such as abdominal 
pain, toothache, relief of hunger and pain. In infants, it was used to alleviate colic and 
as a calming agent (Gericke and Viljoen, 2008; Harvey, 2011).  It was normally chewed 
(this route of administration resulted in its nickname ‘Kougoed’, while ‘Kanna’ was its 
folk name) but can also be consumed in the form of tea or snuff. Recently it has 
received more interest as a potential anxiolytic or anti-depressant as a result of its 
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psychoactive nature. Indeed, anecdotal use describes “intoxication” as an indicator 
of use (Gericke and Viljoen, 2008), suggesting that the plant may have mood-altering 
effects.   
The active compounds to which the mood-altering effects of S. tortuosum are 
ascribed, are known as alkaloids. There are four primary alkaloids within the plant 
namely: mesembrine ((3aS,7aS)-3a-(3,4-dimethoxyphenyl)-1-methylhexahydro-1H-
indol-6(2H)-one), mesembrenone ((3aR,7aS)-3a-(3,4-dimethoxyphenyl)-1-methyl-
3,3a,7,7a-tetrahydro-1H-indol-6(2H)-one), mesembrenol ((3aR,6 S,7aS)-3a-(3,4-
dimethoxyphenyl)-1-methyl-2,3,3a,6,7,7a-hexahydro-1H-indol-6-ol) and mesembranol 
((3aS,6 R,7aS)−3a-(3,4-dimethoxyphenyl)−1-methyloctahydro-1H-indol-6-ol) 
(Krstenansky, 2017) (Fig.2.8). Mesembrenone content is the most variable between 
plants, but mesembrine is always the major alkaloid (Shikanga et al., 2012). 
Fig.2.8 Active compounds in Trimesemine (mesembrine-rich S. tortuosum). 
           
UPLC-MS chromatographic separation of alkaloids in TRI. Compounds eluted as follows: Δ7-
mesembrenone, mesembrenone, and mesembrine (Coetzee et al., 2016). 
 
Although, animal studies have been carried out to determine the effects of S. 
tortuosum, limited pharmacological and clinical studies have been conducted. Even 
though there is evidence supporting the beneficial effects of this plant, it remains 
essential to determine the adverse effects. Knowing the beneficial and detrimental 
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effects of the product is will allow the consumer to make an informed decision, prior 
to using the treatment.   
A number of early studies have proposed that S. tortuosum acts as both a SSRI as well 
as a phosphodiesterase type 4 (PDE4) inhibitor (Harvey et al., 2011). Zembrin, a 
commercially recognised S. tortuosum product, was pharmacologically processed to 
determine possible receptor binding. From this it was suggested that the whole 
product has a significant inhibitory capacity for the serotonin (5HT) transporter, GABA 
receptor, δ2-opioid receptor, µ-opioid receptor, cholecystokinin-1. Following this they 
aimed to establish whether individual alkaloids could be responsible for this inhibition. 
From this it was observed that significant inhibition was present for SERT in the presence 
of mesembrine (Harvey et al., 2011). Furthermore, they attributed the PDE4 inhibitory 
activity to mesembrenone. This inhibitory effect of S. tortuosum on the 5HT transporter, 
offers support to S. tortuosum use as an antidepressant.  
In support of this hypothesis, another study was conducted using different doses of S. 
tortuosum (10 mg/kg and 80 mg/kg) which was administered intraperitoneally. The 
rodent forced swim test, a well-recognised model with which to determine the 
efficacy of an antidepressant, indicated an antidepressant effect with only the low 
dose (10 mg/kg) treatment (Schell, 2014). Somewhat similar to this, doses of 5 and 10 
mg/kg of S. tortuosum (Trimesemine™) was employed to elucidate psychological 
effects in rats making use of the elevated plus maze (Smith, 2011).  Results indicated 
that there was a decrease in CORT and self-soothing behaviour with the low (5 mg/kg) 
dose. Although the high (10 mg/kg) dose resulted in some undesirable reactions, this 
could be ascribed to the fact that the extract used was much cruder when compared 
to which was used prior to this study.   
A novel therapeutic avenue which may have relevance is cannabinoid receptor 1 
(CB1). This receptor has been reported to play a role in emotional processing and is 
co-localised with 5HT. Studies have reported that CB1 inhibition could potentially result 
in an antidepressant effect (Akirav, 2011; Pietrzak et al., 2014). Research by Lubbe et 
al., (2010) observed that whole S. tortuosum extract (0.037 mg/ml), and not individual 
compounds, have an inhibitory action on the CB1 receptor, which could offer an 
alternative, or additional, pathway by which to explain the antidepressant effects 
which have been reported (Loria et al., 2014).  
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In contrast to earlier suggestions of a SSRI action for S. tortuosum, Coetzee et al., (2015) 
suggested that S. tortuosum is primarily a MRA, with a secondary SSRI function. In 
addition to the MRA property this study also reported mild inhibitory effect on the 
monoamine oxidase A enzyme. This activity could offer another explaination to the 
possible antidepressant effects. It is important to note that this study made use 
ofTrimesemine™, mesembrine-rich alkaloid, while other extracts are normally low in 
mesembrine. This difference in the mesembrine content could explain why other 
studies have not reported the monoamine release activity. In addition, both Loria et 
al., (2014) and Coetzee et al., (2016) suggested a minimal inhibition of 
acetylcholinesterase (AChE) activity.  
There is limited information regarding the endocrine effects of the plant. As mentioned 
before, this information is essential, as it affects consumer safety and efficacy. Smith 
and Swart (2016) comprehensively reported on the effects of high-mesembrine S. 
tortuosum (Trimesemine™) extract on the glucocorticoid, mineralocorticoid and sex 
steroid pathways in an in vitro model using human adrenocortical (H295R) cells. It was 
observed that there was a dose-dependent decrease in both basal and stimulated 
production of the following steroids: cortisol, coticosterone (CORT), aldosterone 
(ALDO), 17-hydroxyprogesterone (17OHPROG), PROG, 16α-hydroxyprogesterone 
(16OHPROG), A4, T, 11OHA4, while PREG was increased. These changes were 
reported at high concentrations (1 mg/ml), with the exception of A4 and T, which 
reported decreases at doses ranging between 0.0001 to 1 mg/ml. Therefore it is 
possible that S.tortuosum exerts its inhibitory effects through the CYP17 or   3βHSD 
enzymes (Smith and Swart, 2016). Data obtained for androgens using H295R cells 
cannot conclusively determine the effect on gonadal steroidogenesis, as there are 
Slight differences between the cell types. 
Toxicology is a major factor which must be accounted for when assessing a potential 
therapeutic agent. Fortunately, several toxicology studies have been conducted and 
none have reported severe adverse effects related to the product (Zembrim at 8mg 
and 25mg, human subjects) (Nell et al., 2013). Therefore, given the potential of this 
seemingly safe drug, it is imperative to determine whether potential undesired side-
effects as normally associated with anti-depressant treatment, is associated with this 
plant.    
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2.9 Summary 
To summerise, it is evident that there is interaction between the HPA and HPG axis, 
furthermore in the context of depression, there appears to be an inhibitory effect on 
the HPG axis via the HPA axis. Antidepressants are currently the first line of therapy for 
the treatment of depression, but these drugs have been associated with the 
dysregulation of sexual function. For this reason people have looked to alternative 
therapies, which can alleviate the symptoms, but without the cost of sexual 
dysfunction. One of the compounds of interest in S. tortuosum, which has reported 
limited side effect in human and animal studies. As sexual dysfunction results from 
endocrine disruption, it is essential to determine the effect on the endocrine system 
when investigating new treatment modalities 
 
2.10 Hypothesis and aims 
For this project it was hypothesised that the proven effective anti-stress dose of 
Trimesemine™ (a mesembrine-rich S.tortuosum) would not have undesired endocrine 
disruptive effects in the context of gonadal steroidogenesis. 
In order to test this hypothesis, the following aims were formulated: 
 The investigation of potential inhibitory effects of Trimesemine™ on selected 
p450 enzymes required for T production, in a human kidney cell culture 
transfected with 17βHSD 
 To investigate gonadal steroidogenesis in the presence of Trimesemine™ for 
both genders, using primary mixed testis and ovarian cell cultures 
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CHAPTER 3  
METHODOLOGY 
This thesis will present experimental methods and data on three different experimental 
protocols. Firstly, potential inhibitory effects of S. tortuosum on T synthesis was 
investigated in human kidney cells transfected with 17βHSD. This data was followed 
up on in a study using a rat primary mixed testicular cell culture. Lastly, given the 
gender differences observed in the literature, a similar set of experiments was 
performed in rat primary mixed ovarian cell culture. Unique to this project was the two 
primary cultures, as this has not been carried out by our group before, although we 
have conducted research on several other cell culture models. 
As per standard protocol, experiments were run in triplicate and repeated at least 
three times (i.e. for primary cultures, different animals were also used). 
 
3.1 Experiment 1: Transfection of HEK293  
The aim of this experiment was to transiently transfect HEK293 cells with the 17βHSD 
enzyme which is responsible for the conversion of A4 to T.   
3.1.1 Cell Line and Vectors 
HEK293 cells as well as freezer stocks of E.coli (strain JM109) containing the plasmid 
vectors pCINeo or pcDNA3/17βHSD5 were kindly donated by Prof AC Swart (Dept. 
Biochemistry, Stellenbosch University). The passage number for this experiment ranged 
from 11 to 14. 
3.1.2. Purification of Plasmid DNA 
100 µl of starter cultures of E.coli containing the plasmid vectors pCINeo or 
pcDNA3/17βHSD5 were added to 100ml of Lysogeny broth (LB) media containing 0.1% 
Ampicillin. The culture was homogenised on a shaking incubator (Innova, New 
Brunswick, Canada) at 215 rpm and 37 ºC for 18 hours. The plasmid cDNA (human) 
was purified with NucleoBond® Xtra Plasmid Purification as advised by the 
manufacturer and stored at -20 ºC. The DNA plasmid concentrations and 260/280 
ratios were determined through UV spectrophotometry (Cary60 UV-Vis by Agilent 
technologies; Santa Clara, CA, USA). Restriction enzyme digests using BamH1 and 
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EcoR1, were used to determine the presence of the gene. Purified DNA was stored at 
-20 °C until they were required. 
3.1.3 Transfection of HEK293 cells 
HEK293 cells were cultured at 95% CO2 and 5% N2, at 37°C in supplemented DMEM 
(10% FBS and 1% PenStrep added) (Thermofisher; #41966052, #10499044 and 
#15140122 respectively) and passaged thrice, after which the cells were seeded in 24 
well plates (Nest, #) at a density of 2 x 105 cells per well in 500µl media. After 24 hours 
the media was removed and replaced with un-supplemented DMEM, as 
supplementation has been reported to interfere with transfection success. The cells 
were transiently transfected with 0.5 µg plasmid cDNA per well using X-tremeGene HP 
DNA Transfection Reagent (Roche; #0636654600). The pCINeo vector without the 
plasmid cDNA was used as a negative control for transfection. The cells were 
incubated for 48 hours to allow for transfection to occur. The transfection media was 
removed and the treatment interventions were applied for 12 hours. Treatment groups 
are described in table 3.1. Briefly, 2 doses of Trimesemine™ extract (batch #DV 
SCTR3:E 725076, Verve Dynamics, Somerset West, South Africa) were used in the 
experiment, the high dose at 0.5mg/ml and the low dose at 0.01mg/ml, both in DMEM 
(unsupplemented). Here it is important to state that the mesembrine-rich S.tortousum 
(Trimesemine™) was extracted using propritory methods. These dosages were 
decided upon as previous studies conducted by our group used a range of 0.0001 
mg/ml to 1 mg/ml, thus the dosages used for this range offer a narrower range. The 
A4 (dissolved in absolute ethanol) was used at a concentration of 1µM for all 
experiments. Each well contained 600µl total volume, the balance was achieved 
using supplemented DMEM. After 12 hours media was collected in glass vials (Lasec; 
#G3TUB029Z-013100) and stored at 4ºC for steroid extractions. For a detailed method 
description refer to addendum A. 
Table 3.1. Experimental layout for the HEK293 cell experiment. 
Transfected + Trimesemine™ (Tri) - Trimesemine™ (Tri) 
Untransfected DMEM + Tri + A4 DMEM + A4 
pCINeo DMEM + Tri + A4 DMEM + A4 
17βHSD5 DMEM + Tri(high) + A4 DMEM + A4 
17βHSD5 DMEM + Tri(low) + A4 DMEM + A4 
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3.1.4 LC-MS/MS analysis of steroid metabolites 
A steroid mix containing A4 and T was used to construct a standard steroid range (0, 
0.5, 1, 5, 10, 25, 50, 100 and 250 ng/ml) which was prepared in 500 µl DMEM. The 
internal standards which were used were deuterated testosterone (D2-T; 1.5 ng) and 
deuterated progesterone (D9-P4; 1.5 ng) (Cambridge Isotope Labs; Cat no. DLM 683 
- 0.1 g and Cat no. DLM 7953 – 0.01 g respectively). To each sample, including the 
standards, a 100 µl of internal standard mix was added. Methyl tert-butyl ether (MTBE) 
(Sigma; #34875) was added to the sample in a 1:3 ratio, for this experiment that 
equates to 1.5 ml of MTBE per sample. Samples were vortexed for five minutes and 
placed in -80ºC for 40 minutes, this resulted in a liquid and a solid phase. The liquid 
phase was decanted into clean test tubes (Lasec; #GLAS1T47M13100) and placed 
under a nitrogen stream at 45ºC to dry. Samples were re-suspended in 300 µl of 50% 
Methanol (MeOH) (Merck; #1.06009.2500). After which 150 µl of the sample was 
transferred to mass spectrophotometry (MS) vials (Stargate Scientific; vial #AV5001-0, 
cap #3.005140.1100.1, insert #3.004025.060E.1) and stored at -20ºC until UPLC-MS/MS 
analysis. For detailed method refer to addendum D. 
3.1.5 UPLC-MS.MS conversion  
As previously described (Storbeck et al., 2013; Swart et al., 2013) steroids were 
detected with UPLC (ACQUITY UPLC, Waters, Milford USA) using a Phenomenex 
Kinetex PFP (2.1 mm x 100 mm x 2.6 mm) column. The mobile phase was made of 
solvent A and solvent B consisting of 1% formic acid and 49%: 49%:2%, 
methanol:acetonitrile: isopropanol, respectively (Scholms et al., 2012). The gradients 
for separations were as indicated by Swart et al., (2013). The total run time was 5 min 
and the injection volume was 5 µl. For the quantification of steroids the Xevo triple 
quadrupole mass spectrometer was used. Using an electrospray probe in the positive 
ionisation mode (ESI+) steroids were assessed with the multiple reaction monitoring 
(MRM) mode table 3.2. The settings used were as follows: capillary voltage of 3.5 kV, 
source temperature 120°C, desolvation temperature 400°C, desolvation gas 900 l h−1 
and cone gas 50 l h−1. Data was assembled with the Masslynx software version 4.1. A 
standard curve was produced using the standards and this was used to quantify the 
concentration of steroid present in each sample. 
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Table 3.2. UPLC-MS/MS parameters for the separation of four steroid metabolites. 
Retention time (RT), parent ion, cone voltage (CV), daughter ions and collision energy 
(CE) is shown.a Mass transition of the daughter ion used as quantifier; b Mass transition of 
the daughter ion as qualifier.  
Steroid 
metabolite 
Retention 
time (min) 
Parent Ion 
(M+H)+ 
CV 
Daughter 
Iona (M+H)+ 
CE 
Daughter ionb 
(M+H)+ 
CE 
A4 3.24 287.2 30 96.9 15 108.8 15 
T 3.07 289.2 30 97.2 22 109.0 22 
D9-P4 4.22 324.2 30 100 20 113 25 
D2-T 3.12 291 30 99.1 20 111.25 20 
Androstenedione (A4); Testosterone (T); deuterated progesterone (D9-P4); deuterated 
testosterone (D2-T). 
 
3.2 Experiment 2: Primary Testicular Cell Isolation 
As Leydig cells are the primary site for the production of androgens, the aim was to 
isolate these cells. Testes were obtained from routinely euthenised mice (C657BL/6 
mice), collection occurred once they were culled and therefore ethical approval was 
not required. Testes were kindly provided by the Tygerberg Hospital Animal Unit.  
3.2.1 Isolation of Leydig Cells 
Leydig cell isolation was performed as previously described by Raucci et al., (2014). 
Briefly, the testes were decapsulated and incubated in DMEM/F12 (Thermosfischer; 
#BE04-687F/U1), containing 0.25mg/ml collagenase-dispase (Sigma; #10269638001), 
in a shaking incubator (mrc orbital shaking incubator) for 20 minutes to allow for 
digestion of connective tissue. This mixture was then removed from the shaking 
incubator and allowed to settle for five minutes. The contents was then passed 
through a 70 µm cell strainer (Falcon; #352360) and centrifuged for eight minutes at 
250 xg (Eppendorf Centrifuge 5804 R; #5805AK162114). The pellet was washed once 
with Hanks Balanced Salt Solution (HBSS) (Thermofisher; #14185-048) containing 
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1mg/ml bovine serum albumin (BSA). The crude suspension was loaded onto a 
discontinuous Percoll (Sigma; # 10378016) gradient (5ml of 20%; 10ml of 40%, 10ml of 
60% and 3ml of 90%;  made up in HBSS) before centrifugation for 20 minutes at 800 xg. 
After centrifugation the third layer from the top was removed and diluted with two 
parts HBSS-BSA, this was centrifuged for 10 minutes at 350 xg. The pellet was re-
suspended in DMEM/F12 (supplemented with 10% FBS and 1% PenStrep).  
This method was attempted but did not yield appropriate cell counts for experimental 
purposes. For this reason as well as support offered by literature (Perrard-Sapori et al., 
1987; Lejeune et al., 1998) mixed testicular cultures were performed.  
3.2.2 Mixed Testicular Culture 
The method was adapted from Hseuh (1980). Briefly, the testes were harvested and 
each testes pair was placed in an eppendorf containing supplemented DMEM/F12 
(1% PenStrep) media. The testes were then decapsulated. This cells mass was placed 
in a DMEM mixture containing 0.4% Collagenase/Dispase and 0.1% BSA and 
incubated at 37°C for 90 minutes. The mixture was washed twice with DMEM (10% FBS 
+ 1% PenStrep). The cell mass was evaluated under a microscope and a mixture of 
cells were observed. After this was established the testis mixture was cultured in 
supplemented DMEM (10% FBS + 1% PenStrep). 
After plating, the cells were allowed to attach for 24 hours. Following this period media 
was removed and the treatment was initiated. As previously stated the doses of S. 
tortousum used were 0.5mg/ml and 0.01mg/ml. Previous studies by our group noted 
that 10 μM Forskolin was capable of stimulating the cells (Smith and Swart, 2016). 
Therefore this study also stimulated with 10 μM Forskolin, dissolved in DMSO, (Sigma-
Aldrich, #F3917) Pregnenolone (1μM, dissolved in DMSO)(Sigma-Aldrich, 5-PREGNEN-
3B-OL-20-ONE; #P9129) was administered at to all wells to ensure sufficient reaction 
substrate. This dosage of PREG was chosen in accordance with other studies which 
also administered steroids during treatment (Peretz and Flaws, 2013). 10 μM 
Citalopram hydroxybromide (known SSRI) was added (Sigma-Aldrich, #C7861) to 
standard wells only to validate the model and for comparison to potential effects by 
Trimesemine™. This concentration was decided on, as it has been observed to have 
effects in studies within our group prior to this one (Coetzee et al., 2016). The treatment 
design is presented in Table 3.3. After 24 hours the media was collected in glass vials 
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(Lasec; #G3TUB029Z-013100) and stored at 4ºC for steroid extractions. For detailed 
method refer to addendum B. 
Table 3.3. Experimental design for the mixed testicular culture                                                                                                      
      
Tri (Trimesemine™; mesembrine-rich S.tortuosum); Pregnenolone (PREG; 1 µM); Forskolin (10 
µM); Citalopram (10 µM). 
3.2.3 LC-MS/MS analysis of steroid metabolites 
A steroid mix containing A4 and T was used to construct a standard steroid range (0, 
0.01, 0.05, 0.01, 0.25, 0.5, 1, 5, 10, 25, 50 and 100 ng/ml) which was prepared in 500 µl 
DMEM/F12. D2-T (1.5 ng) and D9-P4 (1.5 ng) were the internal standards for this 
experiment (Cambridge Isotope Labs; Cat no. DLM 683 - 0.1 g and Cat no. DLM 7953 
– 0.01 g respectively). Internal standard was added to each sample (100 µl/ sample, 
including the standards). MTBE (Sigma; #34875) was added to the sample in a 1:3 
ratio, therefore 1.5 ml of MTBE was added. Samples were vortexed for five minutes and 
placed in -80ºC for 40 minutes. The liquid phase was decanted into clean test tubes 
(Lasec; #GLAS1T47M13100) and placed under a nitrogen stream at 45ºC to dry. 
Samples were re-suspended in 300 µl of 50% Methanol (MeOH) (Merck; 
#1.06009.2500). From this 150 µl of the sample was transferred to mass 
spectrophotometry (MS) vials (Stargate Scientific; vial #AV5001-0, cap 
#3.005140.1100.1, insert #3.004025.060E.1) and stored at -20ºC until LC/MS analysis. For 
detailed method refer to addendum D. 
3.2.4 UPLC-MS.MS conversion  
As previously described (Storbeck et al, 2013; Swart et al., 2013) steroids were 
detected with UPLC (ACQUITY UPLC, Waters, Milford USA) using a Phenomenex 
Kinetex PFP (2.1 mm x 100 mm x 2.6 mm) column. The mobile phase was made of 
PREG Forskolin Citalopram S.tortuosum 
- - - - 
+ - - - 
+ + - - 
+ - + - 
+ - - + 
+ - - + 
+ + - + 
+ + - + 
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solvent A and solvent B consisting of 1% formic acid and 49%: 49%:2%, methanol: 
acetonitrile: isopropanol, respectively (Scholms et al, 2012). The gradients for 
separations were as indicated by Swart et al., (2013).The total run time was 5 min and 
the injection volume was 5 µl. For the quantification of steroids the Xevo triple 
quadrupole mass spectrometer was used. Using an electrospray probe in the positive 
ionisation mode (ESI+) steroids were assessed with the multiple reaction monitoring 
(MRM) mode table 3.4. The settings used were as follows: capillary voltage of 3.5 kV, 
source temperature 120°C, desolvation temperature 400°C, desolvation gas 900 l h−1 
and cone gas 50 l h−1. Data was assembled with the Masslynx software version 4.1. A 
standard curve was generated using the standards and then this curve was used to 
determine the concentration of steroids within each sample. 
Table 3.4. UPLC-MS/MS parameters for the separation of four steroid metabolites. Retention 
time (RT), parent ion, cone voltage (CV), daughter ions and collision energy (CE) is shown.a 
Mass transition of the daughter ion used as quantifier; b Mass transition of the daughter ion as 
qualifier.  
Steroid 
metabolite 
Retention 
time (min) 
Parent Ion 
(M+H)+ 
CV 
Daughter 
Iona (M+H)+ 
CE 
Daughter ionb 
(M+H)+ 
CE 
A4 3.24 287.2 30 96.9 15 108.8 15 
T 3.07 289.2 30 97.2 22 109.0 22 
D9-P4 4.22 324.2 30 100 20 113 25 
D2-T 3.12 291 30 99.1 20 111.25 20 
Androstenedione (A4); Testosterone (T); D9-P4 (deuterated progesterone); D2-T (deuterated 
testosterone). 
3.3 Experiment 3: Primary Ovarian Culture 
As there is still debate regarding the classification of S.tortuosum, some arguing it is a 
SSRI while other state it is a monoamine releasing agent (MRA), it was necessary to 
evaluate the effect on estrogens as well. There have been reports that both these 
drug classes have endocrine disrupting abilities (Barenys et al., 2009).  
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3.3.1 Ovarian Mixed Culture 
Animals were kindly donated by the Tygerburg Hospital Animal Unit. The animals were 
routinely euthenised, and access was granted once they were euthenised. For this 
study the mice used were wild type C57/BL/6 female mice. It was not established 
during what phase of their cycle they were prior to culling, from our raw data however 
this did not appear to skew the results as all of the control had the same E2 levels. 
For the production of estrogens both the theca and the granulosa cells are required, 
owing to this a mixed ovarian culture was decided on as a model.  
The method was adapted from Magoffin and Erickson (1988). Briefly, ovaries were 
isolated and collected in supplemented DMEM/F12 (1% PenStrep) media, each ovary 
pair was collect in separate eppendorf tubes. The ovaries were washed with 
DMEM/F12, to prevent contamination and then cut into pieces using sterilised scissors. 
The minced ovaries were incubated in supplemented DMEM/F12 (1% PenStrep + 
1mg/ml BSA + 0.02% Collagenase/Dispase) for two hours, this mixed was disturbed with 
a Pasteur pipette every 30 minutes. After the two hours the cells were passed through 
a cell strainer (70 μm) and centrifuged at 250 xg for five minutes. The pellet was 
washed twice with DMEM/F12. 
The cells were plated at a concentration of 4 x 105 cells per well with supplemented 
DMEM/F12 media (10% FBS + 1% PenStrep), they were incubated at 95% CO2 and 5% 
N2, at 37°C. The cells were allowed to attach for 24 hours. Following this period the 
treatment protocol was started. Cells were treated under the following conditions: 10 
μM Citalopram hydroxybromide, 10 μM Forskolin, high dose S.tortuosum (0.5 mg/ml) 
and low dose S.tortuosum (0.01 mg/ml), with the addition of PREG (1μM) for certain 
conditions, as depicted in table 3.5. After 24 hours of treatment, 500 μl of supernatant 
was collected in glass vials at stored at 4 °C, prior to steroid extractions. For detailed 
method refer to addendum C. 
Table 3.5. Experimental layout for ovarian mixed culture 
 Citalopram Forskolin Pregneneolone S.tortuosum 
Control - - - - 
Forskolin - + - - 
Citalopram + - - - 
Tri high dose - - - + 
Tri low dose - - - + 
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Tri high dose + Fors - + - + 
Tri low dose + Fors - + - + 
Tri high dose + PREG - - + + 
Tri low dose + PREG - - + + 
Tri (Trimesemine™; mesembrine-rich S. tortuosum); Fors (Forskolin; 10 µM); PREG (Pregnenolone; 
1 µM); Citalopram (10 µM). 
3.3.2 LC-MS/MS analysis of steroid metabolites 
A steroid mix containing Estrone (E1) and Estradiol (E2) was used to construct a 
standard steroid range (0, 0.01, 0.05, 0.01, 0.25, 0.5, 1, 5, 10, 25, 50 and 100 ng/ml) 
which was prepared in 500 µl DMEM/F12 media. The internal standards which were 
used were D2-T (1.5 ng) and D9-P4 (1.5 ng) (Cambridge Isotope Labs; Cat no. DLM 
683 - 0.1 g and Cat no. DLM 7953 – 0.01 g respectively). Each sample, including the 
standards, received 100 µl of internal standard mix. MTBE (Sigma; #34875) was added 
to the sample in a 1:3 ratio, therefore 1.5 ml of MTBE was added per sample. Samples 
were vortexed for five minutes and placed in -40ºC for an hour, to ensure that the solid 
and liquid phase separate. The liquid phase was decanted into clean test tubes 
(Lasec; #GLAS1T47M13100) and placed under a nitrogen stream at 45ºC to dry. 
Derivitisation of samples have been reported to enhance the detection of the 
estrogens (Nelson et al., 2004). For the purpose of this study samples were derivitisised 
with dansyl chloride using a method previously performed in laboratory of Prof AC 
Swart. Samples were re-suspended in 100 µl Na2CO3 (0.1 M). 100 µl of a dansyl chloride 
solution (2 mg/ml) was added to each sample. The samples were vortexed and 
placed in a pre-heated oven at 60 °C for two minutes.  Once removed from the oven, 
150 µl of the sample was then transferred to mass spectrophotometry (MS) vials 
(Stargate Scientific; vial #AV5001-0, cap #3.005140.1100.1, insert #3.004025.060E.1) 
and stored at -20ºC until LC/MS analysis. For detailed method refer to addendum E. 
3.3.3 UPLC-MS.MS conversion  
As previously described (Storbeck et al, 2013; Swart et al, 2013) steroids were detected 
with UPLC (ACQUITY UPLC, Waters, Milford USA) using a Phenomenex Kinetex PFP (2.1 
mm x 50 mm) column. The mobile phase was made of solvent A and solvent B 
consisting of 1% formic acid and 49%: 49%:2%, methanol: acetonitrile: isopropanol, 
respectively (Scholms et al., 2012). The gradients for separations were as indicated by 
Swart et al (2013).The total run time was 4.2 min and the injection volume was 5 µl. For 
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the quantification of steroids the Xevo triple quadrupole mass spectrometer was used. 
Using an electrospray probe in the positive ionisation mode (ESI+) steroids were 
assessed with the multiple reaction monitoring (MRM) mode table 3.6. The settings 
used were as follows: capillary voltage of 3.5 kV, source temperature 120°C, 
desolvation temperature 400°C, desolvation gas 900 l h−1 and cone gas 50 l h−1. Data 
was assembled with the Masslynx software version 4.1. Standard curves were 
produces for each steroid metabolite with the following concentrations: 0, 0.01, 0.05, 
0.1, 0.25, 0.5, 1, 5, 10, 25, 50, 100 ng/ml. The method was adjusted from one which was 
developed by Dr. Storbeck’s (Department of Biochemistry, Stellenbosch University) 
group in 2016 (UPLC2016BEHDansyl). 
Table 3.6. UPLC-MS/MS parameters for the separation of four steroid metabolites. Retention 
time (RT), parent ion, cone voltage (CV), daughter ions and collision energy (CE) is shown.a 
Mass transition of the daughter ion used as quantifier; b Mass transition of the daughter ion as 
qualifier.  
Steroid 
metabolite 
Retention 
time (min) 
Parent Ion 
(M+H)+ 
CV 
Daughter 
Iona (M+H)+ 
CE 
Daughter ionb 
(M+H)+ 
CE 
E1 (estrone) 3.2 504 20 156 45 171 35 
E2 (β-
Estradiol) 
3.0 506 35 156.00 40 171.00 35 
D9-P4 4.22 324.2 30 100 20 113 25 
D2-T 3.12 291 30 99.1 20 111.25 20 
Estrone (E1); Estradiol (E2); Deuterated Progesterone (D9-P4); deuterated testosterone (D2-T). 
 
3.4 Statistical Analysis 
Statistical analysis was performed using Microsoft Excel 2010 and STATISTICA 64 (TIBCO, 
USA). After basic statistics confirmed normality a One-way or Factorial ANOVA, as well 
as student t-tests were employed, as applicable. Where ANOVA returned significant 
main effects, specific differences between experimental conditions were compared 
using Fisher LSD post hoc tests. Significance was set at p<0.05. Each experiment had 
three technical repeats and each repeat was conducted in triplicate. All data was 
reported using standard error of the mean (SEM). 
Stellenbosch University  https://scholar.sun.ac.za
35 
 
CHAPTER 4 
RESULTS 
4.1 Experiment 1: Transfected HEK293 cultures 
4.1.1 Effect on Androstenedione (A4) 
Human embryonic kidney (HEK293) cells were used for the transfections. This model 
was specifically chosen as Prof AC Swart’s laboratory has performed numerous 
successful transfections using these cells. Additionally, it also allowed the specific 
enzyme under investigation to be over-expressed, thereby ensuring the detection of 
any deviations from its normal function. To determine whether there is an effect of the 
transfection vehicle (pCINeo), the unstransfected cells were compared to cells which 
were transfected with pCINeo, in the presence and absence of Tri™ (0.5 mg/ml). 
pCINeo showed no effect on A4 production (Fig.4.1). 
Fig.4.1. Confirmation that the vehicle used did not affect A4 production or the effect of 
Trimesemine™.  
   
No significant difference between the untransfected and the vector transfected groups in the 
presence and absence of Tri™. The verticle lines represent the groups treated with Tri™ (0.5 
mg/ml) 
The 17βHSD5 enzyme is responsible for the conversion of A4 to T. Thus, for this model to 
be validated the concentration of A4 was assessed, as a successful transfection would 
result in a decreased concentration of A4. From the results in Fig.4.2. it can be seen 
that the concentration of A4 was significantly (p = 0.0066) reduced after transfection. 
These results not only validate the model but also indicate that the transfection was a 
success. 
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 Fig.4.2. Effect of transfection with 17βHSD on production of A4. 
 
A significant decrease was noted after transfection with the plasmid 17βHSD, as expected. This 
validated the model. 
In order to establish whether Trimesemine™ has an effect on the concentration of A4, 
an one-way ANOVA was performed on the 17βHSD5 transfected cells.  None of the 
doses assessed had any significant effect on the concentration of A4 in the 
transfected cells (Fig.4.3).  
Fig.4.3. Effect of Trimesemine™ on the concentration of A4, in 17βHSD5 transfected cells. 
 
Trimesemine™ (Tri); Tri(L) (Trimesemine™ low dose; 0.01 mg/ml); Tri(H) (Trimesemine™ high 
dose; 0.5 mg/ml). No significant difference was present (p = 0.715).  
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4.1.2 Effect on testosterone (T) 
Similar to A4 data, there was no significant difference between the untransfected cells 
and those transfected with the vehicle control (Fig.4.4) regarding the concentration 
of T. Furthermore, Tri™ did not affect T levels at any dose tested in untransfected and 
pCINeo transfected cells. T production was very low under all conditions, as expected. 
Fig.4.4. Confirmation that the vehicle used did not affect T production or the effect of 
Trimesemine™ 
   
Tri™ (Trimesemine™). No significant difference in T concentration in the presence of ST in 
untransfected (p = 0.21) and pCINeo vector (p = 0.10). There was also no effect (p  = 0.24) of 
the vehicle (pCINeo) control on the concentration of T. Vertical lines represent the addition of 
Tri™ (0.5 mg/ml).  
 
 
The next step was to validate the model by determining whether the transfection 
produced an increase in the concentration of T. Fig.4.5. indicates a significant 
increase in the T concentration from basal (untransfected) levels to those cells in 
which the converting enzyme is over expressed. 
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Fig.4.5. Effect of enzymatic transfection on T production.   
  
Significant increase in the T concentration after transfection, p = 0.0000101. 
To determine if Tri™ had an effect on the concentration of T the transfected cells were 
treated with low (0.01 mg/ml) and high (0.5 mg/ml) doses of Tri™ . Fig.4.6 shows that 
there is a significant decrease in T at high doses compared to control and low doses.  
Fig.4.6. Effect of Tri™ on T production.  
  
Tri (Trimesemine™ a mesembrine-rich S.tortuosum). Tri[L] (Trimesemine™ low dose, 0.01 mg/ml). 
Tri[H] (Trimesemine™ high dose, 0.5 mg/ml). # represents a significant difference (p < 0.05; p = 
0.018) between the 17βHSD5 in the absence of Tri compared to high dose Tri. While the ** 
indicates the significant difference (p < 0.05; p = 0.021) present between the low and high 
doses of Tri™ . 
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4.2 Experiment 2: Primary testis mixed cell culture 
4.2.1 Effect on A4 synthesis 
Primary cultures were used to determine whether these effects remained prevalent in 
the tissues responsible for the primary production of gonadococorticoids. Cells were 
stimulated with PREG to determine if an increase in the basal steroid production 
occurred. In Fig.4.7 it is evident that there is a significant increase in the concentration 
of A4 compared to control.  
 Fig.4.7. Effect of pregnenolone on A4 production in testicular cultures 
   
There was a significant increase (p = 0.012) between control compared to PREG 
(Pregnenolone stimulated) groups. 
Another agent known to upregulate adrenal steroidogenesis is Forskolin. As this is 
known to upregulate the biosynthetic machinery, PREG was added together with 
Forskolin with this treatment to prevent possible substrate depletion. To determine 
whether there was increased andogen production in testicular tissue after Forskolin 
stimulation, a student t test was carried out. Forskolin had no significant effect on the 
production of androgens, as noted in Fig.4.8. This together with the results reported 
above, resulted in PREG being the stimulant of choice in all subsequent treatments. 
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Fig.4.8. Effect of Forskolin on A4 steroid synthesis in the testicular tissue.  
 
p = 0.33, no significant effect with the use of Forskolin (FORS) + PREG compared to PREG alone. 
There was no significant effect on the concentration of A4 in the presence of 
Citalopram (Fig.4.9). 
Fig.4.9. Effect of citalopram on the concentration of A4 in testicular cultures. 
  
p = 0.76; there is no significant difference in PREG + Citalopram (10 µM) compared to PREG 
alone. 
Trimesemine™ at low doses did not have an effect relative to the control (PREG 
group), however at high doses there was a significant difference in the concentration 
of A4, in comparison to the control as well as the low dose group (Fig.4.10). 
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Fig.4.10. Effect of Trimesemine™ on A4 production in testicular cultures.  
  
p = 0.74, therefore no significant difference with the low dose Tri (Trimesemine™, 0.01 mg/ml). 
Significant difference (# = p < 0.05; p = 0.04) with the high dose Tri (Trimesemine™, 0.5 mg/ml) 
compared to control (PREG) and low dose Tri (** = p < 0.05; p = 0.011). 
4.2.2 Effect on testosterone synthesis 
To determine whether the increased androgen synthesis was sustained in the 
presence of PREG, a student t-test was used to assess this. From Fig.4.11. it can be 
observed that there is a significant increase in the concentration of T synthesis.  
Fig.4.11. Effect of PREG on T production in testicular cultures 
  
* = p < 0.05. Significant increase (p = 0.014) with PREG stimulation. 
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In terms of T production, in the presence of PREG, similar results were obtained in the 
presence of Forskolin and Citalopram, with neither condition affecting T synthesis 
(Fig.4.12. and Fig.4.13. respectively).  
Fig.4.12. Effect of Forskolin on the concentration of T in the presence of PREG in testicular 
cultures.  
 
Fig.4.13. Effect of Citalopram on the concentration of T in the presence of PREG in testicular 
cultures. 
 
Trimesemine™ did not appear to have a significant effect on the concentration of T 
in the under PREG stimulation (Fig. 4.14). 
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Fig.4.14. Effect of Trimesemine™ on T production in testicular cultures.  
  
 
4.3 Experiment 3: Primary ovarian mixed cell culture  
The ovarian crude culture was treated with Forskolin in an attempt to upregulate 
steroidogenesis, but – similar to testis data – Forskolin did not appear to have an effect 
on estrogen (specifically E2) biosynthesis (Fig.4.15). In these experiments PREG is not 
present unless otherwise stated. 
Fig.4.15. E2 production under control vs. Forskolin conditions. 
  
Similar to the results obtained in the testes mixed cultures, citalopram did not appear 
to have an effect on E2 synthesis at the dosage tested (Fig. 4.16).  
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Fig.4.16. E2 production under control vs Citalopram conditions in ovarian mixed culture.  
  
An ANOVA was preformed to assess the effect of Trimesemine™ on the synthesis of E2  
in the ovarian mixed culture. Although there was not significant difference reported 
relative to the control (Fig.4.17). 
Fig.4.17. Effect of Trimesemine™ on E2 synthesis in ovarian mixed culture.  
 
Tri[L] (Trimesemine™, low dose 0.01 mg/ml); Tri[H] (Trimesemine™, low dose 0.5 mg/ml) 
To determine whether the presence of PREG could increase ovarian steroidogenesis, 
PREG was added together with Citalopram and Tri at low and high doses. However 
the presence of PREG did not affect the concentration of E2, reported in Fig.4.18. and 
Fig.4.19. respectively. 
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Fig.4.18. Effect of citalopram on concentration of E2 in ovarian mixed culture.  
 
Fig.4.19. Effect of Trimesemine™ (Tri) on E2 production in the presence of PREG in ovarian mixed 
culture. 
  
Pregnenolone (PREG); Tri[L] (Trimesemine™ low dose, 0.01 mg/ml); Tri[H] (Trimesemine™ high 
dose, 0.5 mg/ml). 
Although an attempt was made to also assess estrone (E1) levels, levels for this 
hormone was not within the detectable range.  
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CHAPTER 5 
DISCUSSION 
In the context of anxiety and depression, many positive effects of S.tortuosum extracts 
have been reported, by more than one research group ( Terburg et al., 2013; Loria et 
al, 2014; Harvey et al, 2011; Smith, 2011).  A recent study by our group suggested that 
the extract may have potential negative effects on androgen production (Smith and 
Swart, 2016), although this result was not obtained in H295R cells and not in gonadal 
tissue. Nevertheless, since antidepressant and anxiolytic drugs often have endocrine 
disruptive effects (Mennigen et al., 2008; Ilgin et al., 2017; Müller et al., 2012; 
Safarinejad, 2008), it was imperative to elucidate this potential side-effect of S. 
tortuosum. 
In the first experiment, potential effects of a mesembrine-rich S.tortuosum (Tri™) on 
17βHSD5 were investigated. Human embryonic kidney (HEK293) cells were used as 
these have proved effective with transient expression of enzymes involved in the 
biosynthesis of steroids (Panter et al., 2005; Toit, 2015; Barnard, 2017). To exclude 
potential confounding effects from the transfection protocol itself, we confirmed that 
the vector (pCINeo) alone did not have an effect on the steroid synthesis and the 
quantity of the measured steroids A4 and T were similar to that of the untransfected 
cells.  Therefore, the changes which were observed can be attributed to the 
overexpressed enzyme (17βHSD5).  
17βHSD5 is responsible for the conversion of A4 to T, but also assists the reverse reaction 
from T to A4. To validate the model, it was necessary to determine whether the 
overexpression of 17βHSD5 resulted in detectable changes in the steroid 
concentrations produced in culture. This was indeed the case, as there was more A4 
present in the untransfected cultured HEK293 cells compared to the 17βHSD5 
transfected cells, with the opposite result for T, indicating that this transfection favours 
the conversion of A4 to T.  
After validating the model, the effects of Tri™ was assessed. Tri™ was administered at 
a proven effective dose (0.01 mg/ml) and a high dose (0.5 mg/ml). These doses are 
within a narrower range than doses used previously (Smith and Swart, 2016; Coetzee 
et al., 2016), but the 0.01 mg/ml dose – which was also included as calculated from 
the recommended dose suggested by manufacturers – is the dose which has 
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consistently been shown to have beneficial effects. The higher dose was included 
here to enable illustration of potential dose-dependent effects.  Current results 
suggest that the recommended dose did not have disruptive effects in the context of 
A4 and T. The high dose of Tri™ appeared to inhibit conversion of A4 to T, suggesting 
inhibition of the 17βHSD5 enzyme. To conclusively establish an inhibitory effect of 
17βHSD5 it is necessary to evaluate the concentration of DHEA relative to 
androstenediol, as this enzyme is required for this conversion as well. It is noteworthy 
that the decrease in T observed with the high dose is not as a result of substrate 
depletion – the A4 data at high dose Tri™ is not different from the control. As the 
general concentration of A4 was greater than that of T, it could be possible that 
undetectable changes in A4 synthesis can transmute to observable changes in the 
concentration of T. This interpretation is in line with previous reports by Smith and Swart 
(2016), who reported a dose of 0.0001 mg/ml to decrease the production level of A4 
significantly in adrenal cells. It is important to note however that these cells (H295R) 
were not similar to the cells used in this study (HEK293), so that treatment doses may 
not necessarily be directly comparable, as H295R cells could be more sensitive, given 
their inherent ability for de novo steroid synthesis (Scholms et al., 2012, (Nielsen et al., 
2015). This model supports the notion that mesembrine-rich S.tortuosum at high doses 
may have the ability to inhibit the 17βHSD5 enzyme. 
H295R and HEK293 cell lines are commonly used to investigate enzyme inhibition 
activity, however neither of these cell models are analogues to the primary site of 
gonadocorticoid production. Thus, in an attempt to elucidate the effects of S. 
tortuosum in more relevant models, primary gonadal mixed cell cultures were used to 
further elucidate androgenic or estrogenic effects in the tissues responsible for their 
primary production (testes and ovaries, respectively).   
Initially, Leydig cell isolation were attempted as the model for male gonadal culture. 
However, this proved more difficult than expected and yielded a low cell viability. This 
was possibly unsuccessful owing to the small size of the testes, as most studies 
performing primary isolations used larger experimental animals, such as rats and pigs 
( Seaz et al., 1983; Raucci et al., 2014). Crude cultures of testicular tissue have been 
carried out and yielded results similar to those of cruse cultures, for these reasons 
mixed cell cultures were chosen (Hsueh, 1980; Saez, 1983). The mixed culture 
produced enhanced cell viability. At the point during which the experiments were 
carried out Leydig cells were not in our possession, since then Leydig cells have been 
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acquired, and future studies will make use of them. These cells were kindly donated 
by Prof R. Henkel (university of the Western Cape). Addition of PREG to culture 
conditions increased steroid synthesis significantly for both the production of A4 and T 
as also reported in the literature (Hall et al., 1987).  In contrast, although the addition 
of Forskolin is known to generally stimulate steroid production in H295R cells (Nelson et 
al., 1999; Chaturvedi et al., 2004; Scholms et al., 2012; Smith and Swart, 2016), it did not 
have a significant effect on gonadal cell culture. Therefore, PREG was used to 
stimulate the steroid pathway instead of Forskolin.  
Citalopram was chosen as a standard SSRI treatment, as a comparison to S.tortuosum. 
Literature has reported that drugs with SSRI effect possess endocrine disrupting effects, 
which is most often reflected as a decrease in T levels (Gregorian et al., 2002; 
Safarinejad, 2008; Erdemir et al., 2014; Taylor and Balon, 2014;). According to current 
results, there does not appear to be a significant difference with the administration of 
10 μM Citalopram on the concentration of A4 or T detected from the testicular cells, 
nor does it appear to alter the E2 biosynthesis of the ovarian cells. We have previously 
shown this dose of Citalopram to exert SSRI effects in vitro (Coetzee et al., 2016). 
However, it is possible that this dose of citalopram was too low to illustrate effects on 
T production. This is supported by literature from Hansen et al., (2017) and Müller et al., 
(2012) who reported significant decreases in T concentration at doses of 10 µM 
(Citalopram) and significant estrogenic effects at 17 µM.  
There is limited information regarding the changes in estrogens with the administration 
of SSRI on female sex hormones, however some have reported estrogenic effects for 
flovoxetine (Mennigen, 2008; Müller et al., 2012). Although results from this study did 
not yield significant changes with the administration of 10 μM Citalopram, but this 
could simply be due to the concentration being too low. Our data is in accordance 
with Hansen et al., (2017) who also did not observe changes in E2 at a dose of 10 µM 
citalopram. Müller et al., (2012), however reported effects at 17 µM using another SSRI, 
flovoxetine. It has been reported that the serum concentrations for citalopram range 
from 15-124 ng/ml, thus the dosages which are used may never be achieved in the 
body (Devane, 1999). Contradictory to this Hodgson et al., (2013) reported that there 
is not a linear relationship between the therapeutic effect and the serum 
concentration of the SSRI. Nevertheless, taken together, in retrospect, a higher 
concentration of citalopram may have produced more suitable results for 
comparison. 
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In terms of the medicinal plant under investigation, S.tortuosum was shown in both the 
HEK293 and primary testis culture models, to decrease A4 and/or T concentration at 
the high dose only, while E2 production by ovarian cells were not significantly affected 
at either dose. The reduction of A4 (testicular culture) with the high dose of Tri™ is 
suggestive of an upstream inhibition of the 3βHSD enzyme, as proposed by Smith and 
Swart (2016). With the decrease in T (HEK293 cells) at this dose, the inhibition of 17βHSD5 
cannot be negated.  
While no changes were observed for E2, which is a positive finding, as others with 
similar mechanisms of action (MRA or SSRI) have estrogenic activities. As mentioned 
earlier E1 was assessed but when it as measured it as below the detectable range. A 
possible explanation for the poor detection of E1, could suggest there is an increase 
in the activity of the 17βHSD, indicative of an estrogenic effect. One would expect an 
increase in the concentration of E2 relative to the control, yet there was no statistical 
difference found. Taking the androgen (A4 and T) results into consideration which 
suggests an inhibition of 17βHSD, the increased 17βHSD is unlikely. The poor detection 
of E1 could simply be explained by the model, which may not have seen sensitive 
enough to allow the detection of E1, another possible explanation could be that E1 
occurs predominantly in postmenopausal women. E2 is the more potent of the two 
steroids and is required for a host of functions.  
S.tortuosum has been shown to be have both SSRI (Harvey et al., 2011; Terburg et al., 
2013) and monoamine releasing effects (Coetzee et al., 2015). It is therefore necessary 
to put current results into context of literature on both SSRIs and MRAs. From current 
results, it appears that Tri™ does not have similar effects as those reported for SSRI (as 
already discussed in the context of the citalopram data), although only at the high 
dose (0.5mg/ml) which far exceeds the dose recommended for treatment. Therefore, 
these androgen-related side-effects should probably not be experienced by 
individuals after S.tortuosum consumption. In addition, given the high risk of 
overdosing in patients suffering from depression, a decreasing A4/T level over time 
may be a potential indicator of accidental overdosing. This possibility should be further 
elucidated using long-duration treatment protocols in appropriate rodent models.  
Similar, in the context of the SSRI literature, E2 data suggest very little, or no risk, for 
endocrine disruption in female consumers of the extract. 
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Turning attention now to MRA-related endocrine disruption, several MRAs have been 
reported to have estrogenic effects. For example, methamphetamines, including 
modern “party drugs” such as BZP and TFMPP, were reported to increase estrogen 
regulating elements, reflected as increased proliferative effect  in the estrogen-
sensitive MCF-7 breast cell line (Corrodi et al., 1967; Min et al, 2012), suggesting an 
increased sensitivity to estrogen in response to MRA exposure.  
Publications could not be found which focused on the effects of MRA drugs on actual 
estrogen levels, perhaps due to the general lack of research using female subjects, 
which is only starting to be addressed in the literature. One relatively old study in 
ovariectomised rodents reported that administration of estradiol benzoate decreased 
monoamine oxidase activity in the female brain (Luine et al., 2017). Although this 
suggests cross-talk between the monoamine and androgen systems, subsequent 
literature seems to have largely neglected to report data which may further 
contextualise current data. Thus, to err on the side of caution, although current data 
does not suggest a decrease in estrogen levels to be a potential side-effect of 
S.tortuosum, the possibility of an effect at the level of estrogen receptors, which may 
modulate estrogen sensitivity, remains to be elucidated. 
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CHAPTER 6 
CONCLUSION 
Taken together, current data suggest that gonadal tissue may be less sensitive to the 
inhibitory effect of S.tortuosum previously illustrated in adrenal cell T synthesis. 
Secondly, the recommended dose of S.tortuosum does not appear to change 
gonadal production of either male or female sex hormones. 
Therefore, S.tortuosum extract may be superior to other antidepressant drugs in that it 
does not result in androgenic or estrogenic responses, in doses recommended for the 
treatment of depression and anxiety.  
Although this cell study suggests there is no endocrine disruptive effect in terms of the 
sex steroid production, in both genders, conclusive evidence requires further in vitro 
studies on gonad specific cell line as well as in vivo experiments. 
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ADDENDUM A 
SOP: Transfection of HEK293 Cells 
 Seed 1 x 106 HEK293 cells in T75 cultures flasks  
 Media used = DMEM + 1% PenStrep + 10% FBS 
 Grow cells until they are 3 passages from the initial passage (eg. P15 – P18) 
 Plate the cells at 2.5 x 105 cells per well in a 24-well culture plate 
 Leave for 24 hours to attach 
 Transfect cells with DNA using the XtremeGene Transfection Reagent 
 Transfection reagent to DNA ratio is 3:1 
 Final reaction volume per well should be 500 µl 
 Media for transfection must be unsupplemented, for proper transfection 
 Leave in this media for 48 hours 
 After 48 hours remove the transfection media 
 Add the treatment media, making sure each well has a total of 600 µl media, 
to account for evaporation 
 After 24 hours remove 500 µl of supernatant and place in glass test tubes 
 Store at 4 °C until the point of steroid extraction – don’t store for longer than 2 
weeks 
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ADDENDUM B 
SOP: Testicular Mixed Culture 
 Collect the testes in cold supplemented media DMEM/F12 (1% PenStrep + 0.1% 
Gentamycin) – each pair to be collected in its own tube 
 Decapsulate testes and place the cell mass in DMEM/F12 media containing 0.4% 
Collagenase/Dispase and 0.1% BSA 
 Place in the shaking incubator 
 Allow enzyme digestion to take place to 90 minutes, pipetting at 30 intervals 
 After 90 min, wash the cells 3 times at 1500 rpm for 5 min in DMEM/F12 
 Cells were plated at 5 x 105 cells/ well in supplemented DMEM/F12 (1% PenStrep) in a 
48 well plate 
 Allow the cells to recover for 24 hours in supplemented DMEM 
 Remove the media and add the desired treatment media 
 Leave the cells in the treatment media for 24 hours  
 Collect supernatant after 24 hours and store in in the glass vials  
 Sores the samples at 4 °C until the point of steroid extraction 
 
***Adapted from Hseuh (1980). 
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ADDENDUM C 
SOP: Ovarian Mixed Culture 
 Collect the testes in cold supplemented media DMEM/F12 (1% PenStrep + 0.1% 
Gentamycin) – each pair to be collected in its own tube 
 Cut the ovaries into pieces (4 or more) 
 Place the ovaries in DMEM/F12 containing 2% Collagenase/Dispase and 1 mg/ml BSA 
 Place in the shaking incubator  
 Leave for 2 hours, pipetting at 30 min intervals 
 Pass the ovaries though a cell strainer 
 After the incubation wash 3 times with DMEM/F12 at 250 g for 5min 
 Plate at Cells ere plated at 5 x 105 cells/ well in supplemented DMEM/F12 (1% PenStrep 
+ 10% FBS) in a 48 well plate 
 Allow the cells to recover for 24 hours in supplemented DMEM 
 Remove the media and add the desired treatment media 
 Leave the cells in the treatment media for 24 hours  
 Collect supernatant after 24 hours and store in in the glass vials  
 Sores the samples at 4 °C until the point of steroid extraction 
 
**Adapted from Magoffin and Erickson (1988). 
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ADDENDUM D 
SOP: Steroid Extractions for A4 and T 
 Make up Standards 
STANDARD 
CULTURE MEDIA 
(µL) 
STEROID MIX 
(1000ng/Ml) 
CONCENTRATION 
(ng/ Ml) 
S0 500 0 0 
S1 500 0.5 1 
S2 500 2.5 5 
S3 500 5 10 
S4 500 12.5 25 
S5 500 25 50 
S7 500 50 100 
S8 500 125 250 
 
MTBE extraction Method 
 Add internal standard to the sample BEFORE adding MTBE (15ng per sample to 150µL 
methanol, you want 1ng sample at the end) 
 Prepare the calibration or standard series per sample batch. Standards are made in 
the same way as the samples to limit the error in analysis. Make up the desired 
concentration of media and add the media : steroid to MTBE in a 1:3 ratio. When 
working up, remember to add internal standard (1ng/mL sample) 
 Add 3mL MTBE for each mL of cell media 
 Mix and vortex the samples 
 Freeze (-80 °C) until the samples have until there are two distinctive layers  
 Transfer the clear layer to a clean test tube 
 Evaporate the MTBE with a N2 stream  
 Reconstitute in 300 µl of 50% methanol (LCMS grade) 
 Add to 150 µl  the CMS vials and store at -20°C until samples are evaluated 
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ADDENDUM E 
SOP: Steroid Extractions - Estrogens 
 Make up Standards 
STANDARD 
CULTURE 
MEDIA (µL) 
STEROID MIX 
(1000ng/Ml) 
STEROID MIX 
(1ng/Ml) 
CONCENTRATION 
(ng/ Ml) 
S0 500  0 0 
S1 500  5 0.01 
S2 500  25 0.05 
S3 500  50 0.1 
S4 500  125 0.25 
S5 500 0.25  0.5 
S6 500 0.5  1 
S7 500 2.5  5 
S8 500 5  10 
S9 500 12.5  25 
S10 500 25  50 
S11 500 50  100 
 
MTBE extraction Method 
 Add internal standard to the sample BEFORE adding MTBE (15ng per sample to 150 µl 
methanol, you want 1ng sample at the end) 
 Prepare the calibration or standard series per sample batch. Standards are made in 
the same way as the samples to limit the error in analysis. Make up the desired 
concentration of media and add the media: steroid to MTBE in a 1:3 ratio. When 
working up, remember to add internal standard (1ng/mL sample) 
 Add 3mL MTBE for each mL of cell media 
 Mix and vortex the samples 
 Freeze (- 80 °C) until the samples have split  
 Transfer the clear layer to a clean test tube 
 Evaporate the MTBE with a N2 stream 
 Resuspend the dried samples in 100 µl of 0.1 M Na2CO3 
 Add 100 µl dansyl chloride solution (2 mg/ml in acetone) to each sample 
 Store samples at – 20 °C  - samples must be analysed within 18 hours of the dansyl 
chloride addition (prevents sample degradation) 
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